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ABSTRACT OF DISSERTATION

CONTRIBUTION OF NUCLEUS ACCUMBENS CORE TO IMPULSIVE CHOICE:
ROLE OF DOPAMINE AND GLUTAMATE SYSTEMS
Impulsive choice refers to the inability to delay gratification and is associated with
increased drug abuse vulnerability. Understanding the underlying neural
mechanisms linking impulsive choice and drug abuse can contribute to improved
treatment options for individuals with substance use disorders. Evidence
suggests a major role for nucleus accumbens core (NAcc) in impulsive choice
and the reinforcing effects of drugs of abuse. The neurotransmitters glutamate
(Glu) and dopamine (DA) are implicated in the neural adaptations observed in
drug addiction; however, the role of intra-NAcc Glu and DA in impulsive choice is
unclear. Rats were trained in a delay discounting task, in which animals chose
between a small, immediate reinforcer and large, delayed reinforcer.
Consistently choosing the small, immediate reinforcer was considered to reflect
increased impulsivity. Following delay discounting, in vitro receptor
autoradiography was performed to quantify the number of N-methyl-D-aspartate
(NMDA) receptors and dopamine transporters (DAT) in NAcc and nucleus
accumbens shell (NAcSh). In a separate experiment, rats were trained in delay
discounting and were implanted with guide cannulae into NAcc. Following
surgery, rats received microinfusions of either a) the Glu-selective ligands MK801 (noncompetitive NMDA receptor channel blocker; 0, 0.3, and 1.0 µg), AP-5
(competitive NMDA receptor antagonist; 0, 0.3, and 1.0 µg), ifenprodil (NMDA
NR2B subunit antagonist; 0, 0.3, and 1.0 µg), and CNQX (AMPA receptor
antagonist; 0, 0.2, and 0.5 µg) or b) the DA-selective ligands SKF 38393 (D1-like
receptor agonist; 0, 0.03, and 0.1 µg), SCH 23390 (D1-like receptor antagonist;
0, 0.3, and 1.0 µg), quinpirole (D2-like receptor agonist; 0, 0.3, and 1.0 µg), and
eticlopride (D2-like receptor antagonist; 0, 0.3, and 1.0 µg). In NAcc and NAcSh,
NMDA receptor and DAT expression did not differ between high and low

	
  

	
  

	
  

impulsive rats. Furthermore, intra-NAcc administration of NDMA and DA
receptor ligands did not significantly alter impulsive choice. These results
suggest that Glu and DA systems within NAcc do not directly mediate impulsive
decision making. Future work is needed to determine the precise role of NAcc in
mediating impulsive choice.
KEYWORDS: Impulsive Choice, Nucleus Accumbens Core, Glutamate,
Dopamine, Rat
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Chapter 1: Introduction
Impulsivity
Impulsivity is a multifaceted construct that includes lack of inhibitory
control, lack of forethought, and inability to delay gratification (see Evenden,
1999; Whiteside & Lynam, 2001 for reviews). The construct of impulsivity can be
measured using personality questionnaires and behavioral studies. Numerous
personality questionnaires have been developed to measure impulsivity. Some
of the most widely used questionnaires include the Barratt Impulsiveness Scale11 (BIS-11; Patton, Stanford, & Barratt, 1995), which encompasses the
subscales attentional impulsiveness, motor impulsiveness, and non-planning
impulsiveness; the I-7 Impulsiveness Questionnaire (Eysenck, Pearson, Easting,
& Allsopp, 1985), which is composed of the subscales impulsiveness,
venturesomeness, and empathy; and the UPPS Impulsive Behavior Scale
(Whiteside & Lynam, 2001), which includes urgency, (lack of) premeditation,
(lack of) perseverance, and sensation seeking.
Dickman (1990) emphasizes two broad types of impulsivity: functional and
dysfunctional. Functional impulsivity is defined as the tendency to act with little
forethought when the situation is optimal. In contrast, dysfunctional impulsivity is
defined as the tendency to act with less forethought, which can lead to
problematic decisions. Distinguishing between functional and dysfunctional
impulsivity is important because this distinction illustrates that impulsivity is not
always disadvantageous.
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One criticism of personality measures is that they can suffer from the
“jingle and jangle” fallacies (Block, 1995; see Whiteside and Lynam, 2001 for a
discussion). According to Whiteside and Lynam (2001), the jingle fallacy refers
to situations in which two different impulsivity constructs are given the same
label, and the jangle fallacy refers to situations in which different labels are used
to describe the same construct. These fallacies are problematic because they
can impede our understanding of the underlying processes involved in
impulsivity. One way to avoid the jingle and jangle fallacies is to use behavioral
studies to test the various types of impulsivity.
Impulsive Action and Impulsive Choice
Most of the behavioral procedures measuring impulsivity can be fractioned
into two broad categories: impulsive action and impulsive choice (see
Winstanley, Olausson, Taylor, & Jentsch, 2010 for a full review). Impulsive
action is conceptualized as motor impulsivity; humans and animals that fail to
inhibit prepotent responses are considered to have higher levels of motor
impulsivity. The primary behavioral tasks used to measure impulsive action are
the stop signal reaction time (SSRT), the go/no-go, and the five-choice serial
reaction time (5CSRT) tasks (see Winstanley et al., 2010). In the SSRT,
subjects are required to inhibit responses they have already initiated when
presented with a cue (Logan, Cowan, & Davis, 1984). In go/no-go tasks,
subjects are required to either initiate a response (go) or inhibit a response (nogo) when presented with different cues (Newman, Widom, & Nathan, 1985). In
the 5CSRT task, animals are trained to respond to a stimulus that is presented in
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one of five apertures. The animal is required to wait for a period of time before
initiating a response (Carli, Robbins, Evenden, & Everitt, 1983).
The SSRT and go/no-go tasks can be used with human (Logan et al.,
1984; Newman et al., 1985) and animal subjects (Eagle & Robbins, 2003; Feola,
de Wit, & Richards, 2000; Iverson & Mishkin, 1970; Liu, Heitz, & Bradberry, 2009;
Terman & Terman, 1973), but the 5CSRT is currently only measured in animals.
However, the 5CSRT is considered to be an animal analog of the continuous
performance task, in which humans are required to scan a 5-digit sequence and
respond when the number matches a target stimulus (Rosvold, Mirsky, Sarason,
Bransome, & Beck, 1956; see Winstanley et al., 2010 for a discussion).
Impulsive choice is conceptualized as the inability to delay gratification
and is often measured with delay discounting tasks. The term discounting refers
to the decrease in subjective value of a reinforcer as a function of the delay to its
delivery. In a typical delay discounting procedure, humans and animals choose
between a small magnitude reinforcer delivered immediately and a large
magnitude reinforcer delivered after a delay. Consistently choosing the smaller,
immediate reward over the larger, delayed reward is often considered to reflect
impulsive behavior (Ainslie, 1975). Discounting of delayed rewards is observed
in various species, including humans (e.g., Rachlin, Raineri, & Cross, 1991),
pigeons (e.g., Mazur, 1987), mice (e.g., Mitchell, Reeves, Li, & Phillips, 2006),
and rats (e.g., Richards, Mitchell, de Wit, & Seiden, 1997).
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Delay Discounting Paradigms
Delay discounting is often measured in humans by asking participants to
choose between two hypothetical monetary rewards differing in magnitude
(Rachlin et al., 1991). The value of the larger, delayed monetary reward is held
constant, whereas the value of the smaller, immediate reward is decreased
systematically. The indifference point is the point at which a person switches
their preference from the small, immediate reinforcer to the large, delayed
reinforcer. While there may be some concern about the validity of delay
discounting when hypothetical rewards are used, results indicate similar rates of
delay discounting when hypothetical or real rewards are used (Johnson & Bickel,
2002; Madden, Begotka, Raiff, & Kastern, 2003).
Multiple procedures can be used to measure delay discounting in animals.
In the T-maze (Bizot, Le Bihan, Puech, Hamon, & Thiebot, 1999; Rudebeck,
Walton, Smyth, Bannerman, & Rushworth, 2006), one arm of the maze is
associated with a small magnitude reinforcer, whereas one arm is paired with a
larger reinforcer. If the rat chooses the arm with the larger reinforcer, a gate is
lowered, and the animal is confined to the arm for a fixed delay before receiving
reinforcement. Delays to the larger reinforcer are increased across sessions.
Because the T-maze paradigm is more labor intense relative to using an
automated operant procedure, it is infrequently used (Madden & Johnson, 2010).
Procedures testing delay discounting often rely on the use of operant
conditioning procedures. As discussed by Madden and Johnson (2010), there
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are several common features among studies measuring delay discounting using
an operant procedure. Typically, the animal must perform a response that places
the subject equidistant from the two choice alternatives. Without this control, an
animal may respond on a manipulandum because it is closer to that
manipulandum relative to the alternative manipulandum. Another common
feature is the inclusion of forced-choice trials. During these trials, only one
alternative is available. These trials are included to expose the animal to both
contingencies of reinforcement.
In the adjusting delay procedure, animals are trained to make choices
between a large amount of food delivered after an adjusting delay and a smaller
amount delivered after a fixed delay (Mazur, 1987). Generally, subjects complete
blocks of trials, which consist of two forced-choice trials followed by two freechoice trials. If the subject chooses the smaller reinforcer on both free-choice
trials, the delay to the larger reinforcer is decreased (usually by 1 sec).
Conversely, if an animal chooses the larger reinforcer on both free-choice trials,
the delay to the larger reinforcer is increased. The delay to the larger reinforcer
is not altered if the subject chooses each reinforcer during a block of trials. Upon
achieving stability, the mean adjusting delay is calculated and it is termed as the
“indifference point”. This procedure is repeated across several fixed delays to
the smaller reinforcer, and adjusting delays are plotted as a function of the fixed
delay to the smaller, sooner reinforcer.
The adjusting delay procedure has received some criticism. In one study
Cardinal, Daw, Robbins, and Everitt (2002) trained rats to complete thousands of
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trials in an adjusting delay task. Despite the extensive training, rats never
reached a constrained range of adjusted delays (i.e., adjusted delays never
stabilized). Cardinal et al. (2002) concluded that animals are not sensitive to the
adjusting delay. It is important to note that Cardinal et al. (2002) adjusted the
delay to the large magnitude reinforcer by 20%-30% (range: 0.4 – 9.0 seconds),
whereas Mazur (1987) adjusted the delay in 1-second increments. The large
adjustments to the delay to the large reward in the Cardinal et al. (2002) study
may have resulted in instable indifference points (see Madden & Johnson, 2010).
The adjusting amount procedure developed by Richards et al. (1997) is
similar to the adjusting delay procedure. However, delays stay constant within a
session, whereas the size of the delayed reinforcer varies depending on the
animal’s response on the previous trial. Evidence suggest that the rate of
discounting in an adjusting amount procedure is similar to the discounting
observed in an adjusting delay procedure, suggesting that these tasks share
similar underlying processes (Green, Myerson, Shah, Estle, & Holt, 2007).
Evenden and Ryan (1996) developed a discounting procedure that is
commonly used to measure impulsive choice in both humans and animals. This
task incorporates blocks of trials, in which the delay for obtaining the larger
reward increases within a single session (Evenden & Ryan, 1996), although the
delay for obtaining the large reinforcer can be manipulated between sessions
(Mobini, Chiang, Ho, Bradshaw, & Szabadi, 2000). As the delay of obtaining the
large reinforcer increases, animals switch their preference to the smaller,
immediate reinforcer (Evenden & Ryan, 1996). Importantly, the increased
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discounting observed across a session is not due to satiation, as animals
consistently choose a large reinforcer over a small reinforcer when delivery of the
larger reinforcer is not delayed (Evenden & Ryan, 1996). One advantage of this
procedure is that it provides a measure of sensitivity to delayed reinforcement
during each session. Also, a measurement of sensitivity to reinforcer amount
can be measured each session by examining choice for the large reinforcer
during no-delay trial blocks (i.e., delay = 0 sec).
Although the original study conducted by Evenden and Ryan (1996)
increased the delay across blocks of trials, some studies have examined whether
increasing or decreasing the delay to the larger reinforcer across trial blocks
alters the rate of discounting of that reinforcer. Studies with human participants
have generally shown that increasing the delay within session produces greater
discounting relative to decreasing the delay within session (Robles & Vargas,
2008; Robles, Vargas, & Bejarano, 2009; Stillwell & Tunney, 2012; but see
Robles & Vargas, 2007). Studies with animals have been mixed; Fox, Hand, and
Reilly (2008) reported increased discounting using a descending sequence
relative to an ascending sequence, whereas Slezak and Anderson (2009)
observed no difference in discounting rate using an ascending or a descending
sequence.
Mathematical Models of Discounting
Several mathematical models have been proposed to describe the
relationship between delay and subjective value of a reinforcer. The exponential
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discounting model postulates that the subjective value of a good decreases by a
constant percentage per unit time and can be modeled with the following
equation:
V = Ae-kD
In this equation, V is the subjective value of the delayed reinforcer, A represents
the amount of the reinforcer, D is the delay to the delivery of the reinforcer, and k
is a parameter measuring the rate at which delayed reinforcers are discounted
(Samuelson, 1937). A higher k value indicates a preference for small, immediate
reinforcement.
The exponential model assumes that if a reinforcer is preferred over
another reinforcer at one point in time, it will be preferred at all other points in
time. However, results from studies with humans (Green, Fristoe, & Myerson,
1994) and animals (Ainslie & Hernstein, 1981; Green & Estle, 2003; Green,
Fisher, Perlow, & Sherman, 1981) do not support this hypothesis. For example,
human participants given a choice between a small hypothetical monetary
reward (e.g., $20) delivered immediately and a large hypothetical monetary
reward (e.g., $50) delivered in 1 year often choose the small, immediate reward;
however, if a delay is added to both rewards (e.g., $20 delivered in 1 year vs.
$50 delivered in 2 years), participants often switch their preference to the larger
reward (Green et al., 1994). The exponential model of discounting does not
predict these preference reversals (see Green & Myerson, 2004; Madden &
Johnson, 2010 for reviews).
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To account for preference reversals, the hyperbolic discounting model
proposed by Mazur (1987) is often used, which is modeled with the equation:
V = A/(1 + kD)
The parameters are identical to those described in the exponential function.
There is evidence to suggest that the hyperbolic model provides a better fit of
discounting data relative to the exponential model in humans (Rachlin et al.,
1991; Vuchinich & Simpson, 2000) and animals (Mazur, 1987).
A hyperboloid function can also be used to model discounting of delayed
reinforcers (Green, Fry, & Myerson, 1994). This function is similar to the
hyperbolic function proposed by Mazur (1987), with the exception that the
denominator of the hyperbola is raised to a power of s, which is a nonlinear
scaling of amount and/or time and is generally equal to or less than 1.0 (see
Green & Myerson, 2004 for a review). According to Myerson and Green (1995),
the hyperboloid function provides a better fit of delay discounting behavior
relative to the hyperbolic, although studies with animals show no reliable
difference between hyperbolic and hyperboloid functions (Green et al., 2007;
Mazur, 2000; Richards et al., 1997).
Given the debate surrounding the different theoretical discounting
functions, Myerson, Green, and Warusawitharana (2001) propose a “theoretically
neutral” model of discounting. Instead of using parameter estimates derived from
theoretical models of discounting, Myerson et al. (2001) advocate the use of area
under the curve (AUC) to determine sensitivity to delayed reinforcement. One
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advantage of using AUC is that the distribution of AUC values are normally
distributed, whereas parameter estimates derived from discounting functions
tend to be positively skewed (Myerson et al., 2001), thus allowing the use of
parametric statistical analyses to compare discounting rates in different groups of
subjects.
Relationship between Impulsive Choice and Drug Abuse
Clinical cross-sectional studies indicate that drug users are more
impulsive compared to nonusers (Moeller et al., 2001; Sher & Trull, 1994). In
humans, greater delay discounting is observed in opioid-dependent individuals
(Kirby, Petry, & Bickle, 1999; Madden, Petry, Badger, & Bickel, 1997), cocaine
users (Coffey, Gudelski, Saladin, & Brady, 2003; Heil, Johnson, Higgins, &
Bickel, 2006), methamphetamine-dependent individuals (Hoffman et al., 2006),
alcohol abusers (Field, Christiansen, Cole, & Goudie, 2007; Kollins, 2003; Petry,
2001a, Vuchinich & Simpson, 1998), and cigarette smokers (Bickel, Odum, &
Madden, 1999; Mitchell, 1999; Ohmura, Takahashi, & Kitamura, 2005; Reynolds,
Richards, Horn, & Karraker, 2004). Furthermore, individuals with a history of
substance abuse show greater discounting of crack/cocaine, heroin, and
cigarettes relative to monetary rewards (Bickel et al., 1999; Coffey et al., 2003;
Madden et al., 1997), reflecting the importance of drug reward over monetary
rewards in these individuals.
Although individuals with a history of substance abuse are more impulsive
relative to matched controls, it is unknown if enhanced impulsivity predisposes an
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individual to substance abuse or if prolonged drug use increases impulsivity.
Evidence suggests a bidirectional relationship between impulsivity and drug
abuse (see de Wit, 2009), and preclinical research has been valuable in this
regard. Using a T-maze paradigm to access impulsive choice, Poulos, Le, and
Parker (1995) found that high impulsive (HiI) rats consume more ethanol relative
to low impulsive (LoI) rats. Since the seminal study conducted by Poulos et al.
(1995), others have examined if impulsive choice predicts vulnerability to
different stages of drug seeking. HiI rats acquire cocaine self-administration at a
faster rate (Perry, Larson, German, Madden, & Carroll, 2005; Perry, Nelson, &
Perry, 2008), show greater escalation of cocaine self-administration (Anker,
Perry, Gliddon, & Carroll, 2009), and show greater resistance to extinction (i.e.,
increased responding on a lever in the absence of reinforcement) to cocaine selfadministration (Broos, Diergaarde, Schoffelmeer, Pattij, & De Vries, 2012a)
relative to LoI rats. Also, HiI rats self-administer more nicotine and
methylphenidate relative to LoI rats (Diergaarde et al., 2008; Marusich & Bardo,
2009), and impulsive choice is predictive of reinstatement to nicotine selfadministration (Diergaarde et al., 2008). Thus, increased impulsivity is a
predictor of increased substance abuse vulnerability.
Some studies have used a behavioral economic approach to measure
whether impulsivity is associated with inelastic demand for drugs of abuse. In
this approach, total consumption of a reinforcer, rather than response rate, is
measured. Consumption is measured at a variety of prices (i.e., response
requirements); if an animal continues to respond for the reinforcer as the price
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increases, the demand for the reinforcer is considered to be inelastic. Impulsive
choice is predictive of inelastic demand for cocaine (Koffarnus & Woods, 2011)
and nicotine (Diergaarde, van Mourik, Pattij, Schoffelmeer, & De Vries, 2012).
Interestingly, impulsivity does not predict inelastic demand for alcohol
(Diergaarde et al., 2012), which contrasts with previous research demonstrating
that impulsive choice predicts increased alcohol consumption (Poulos et al.,
1995). These inconsistencies demonstrate the importance of using various drug
self-administration paradigms to determine the precise relationship between
sensitivity to delayed reinforcement and drug abuse vulnerability.
Some caution needs to be taken when interpreting previous studies
examining delay discounting and operant drug self-administration. Stephens et
al. (2010) present one confound to self-administration paradigms. Selfadministration for psychostimulant drugs may not reflect increased motivation to
obtain the drug reinforcer; instead, these drugs produce hyperactivity, which may
increase the likelihood that an animal responds on the drug-paired
manipulandum. Rats that show increased cocaine-induced hyperactivity are
more impulsive in a delay discounting task relative to rats that show an
attenuated response to cocaine (Stanis, Burns, Sherrill, & Gulley, 2008). Thus,
HiI rats may respond more for psychostimulant drugs due to increased druginduced hyperactivity.
Another potential interpretational problem with previous studies assessing
the role of impulsive choice in drug self-administration is that HiI animals may not
respond more for drug because of its reinforcing properties; instead, they may be
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more sensitive to reward-associated stimuli. For example, HiI rats exhibit more
sign-tracking conditioned responses compared to LoI rats (Tomie, Aguado,
Pohrecky, & Benjamin, 1998; but see Lovic, Saunders, Yager, & Robinson,
2011). Also, Diergaarde, Pattij, Nawijn, Schoffelmeer, and De Vries (2009)
showed that high impulsive rats nose poke more for a discrete cue formerly
paired with sucrose delivery.
To avoid these potential confounds, Yates, Marusich, Gipson, Beckmann,
and Bardo (2012) used a non-operant conditioned place preference (CPP)
paradigm to measure drug reward in HiI and LoI rats. Impulsive choice was
predictive of amphetamine CPP; that is, HiI animals spent more time in an
environment previously paired with amphetamine relative to LoI animals (Yates
et al., 2012). These results demonstrate that the increased drug selfadministration of psychostimulants is not simply the result of drug-induced
hyperactivity or increased sign-tracking.
Although increased impulsive choice is predictive of different stages of
psychostimulant addiction, there is little evidence that delay discounting is
associated with opioid self-administration. HiI and LoI rats acquire heroin selfadministration at the same rate and self-administer similar amounts of heroin
(Schippers, Binnekade, Schoffelmeer, Pattij, & De Vries, 2012). Furthermore,
impulsive choice is not predictive of extinction to heroin self-administration or
reinstatement to heroin self-administration (Schippers et al., 2012). Although the
relationship between drug addiction and impulsive choice is postulated to be
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bidirectional (de Wit, 2009), these results suggest that impulsivity is not a
determinant of opioid abuse.
Conversely, despite the clear evidence for impulsive choice being a
predictor of stimulant abuse, research also has demonstrated that drug exposure
affects impulsive decision making. Cocaine administration (systemic and selfadministered) increases impulsive choice in rats (Dandy & Gatch, 2009;
Hernandez et al., 2014; Mendez et al., 2010; Simon Mendez, & Setlow, 2007; but
see Broos et al., 2012a), as does chronic self-administration of amphetamine or
heroin (Gipson & Bardo, 2009; Schippers et al., 2012). Finally, withdrawal from
phencyclidine increases impulsive choice (Carroll, Kohl, Johnson, & La Nasa,
2013; Carroll, Mach, La Nasa, & Newman, 2009). In conclusion, exposure to
drugs of abuse increases impulsive decision making.
Underlying Neuromechanisms Linking Impulsive Choice and Drug Abuse
Understanding the potential underlying neural mechanisms linking
impulsive choice and drug reinforcement can help explain why HiI individuals are
prone to drug abuse. Such information is important for the development of better
treatment options for individuals with substance use disorders.
Neuroanatomical Regions Implicated in Impulsive Choice
To identify the neuroanatomical structures involved in discounting,
techniques such as focal excitotoxic or neurochemical lesions and temporary
inactivation are often used. Several brain regions have been implicated in
impulsive choice, including amygdala (Churchwell, Morris, Heurtelou, & Kesner,
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2009; Winstanley, Theobald, Cardinal, & Robbins, 2004b), dorsal striatum
(Dunnett, Heuer, Lelos, Brooks, & Rosser, 2012), and hippocampus (Abela &
Chudasama, 2013; Cheung & Cardinal, 2005; Mariano et al., 2009). However,
structures within the mesocorticolimbic pathway have received particular interest
due to the major hypothesis that chronic drug exposure augments stimulusreward learning and impairs inhibitory control functions, facilitating relapse-like
behavior (Jentch & Taylor, 1999; Robinson & Berridge, 2003). This portion of the
dissertation will focus on three regions within the mesocorticolimbic pathway:
orbitofrontal cortex (OFC), medial prefrontal cortex (mPFC), and nucleus
accumbens (NAc).
Orbitofrontal cortex (OFC). OFC is implicated in various forms of
decision making, most importantly in updating the value of an expected reward
on the basis of past experience (Gallagher, McMahan, & Shoenbaum, 1999;
Izquierdo, Suda, & Murray, 2004; Roesch & Olson, 2004; Schoenbaum, Chiba, &
Gallagher, 1998; Schoenbaum, Setlow, & Ramus, 2003; see Wallis, 2007 for a
review). OFC also is implicated in drug abuse, as hypoactivity within this region
is observed in individuals with cocaine addiction (Volkow et al., 1993, 1991) and
re-exposure to a drug-paired context activates OFC in nonhuman animals
(Hearing, Miller, See, & McGinty, 2008; Neisewander et al., 2000). Lesions to
OFC decrease cocaine self-administration in rats (Hutcheson & Everitt, 2003; but
see Grakalic, Panlilio, Quiroz, & Schindler, 2010), and inactivation of OFC
attenuates cue-induced cocaine seeking behavior (Fuchs, Evans, Parker, & See,
2004).
	
  

15

	
  

Studies examining the role of OFC in delay discounting behavior have
produced variable results. During performance in an adjusting-delay procedure,
an increase in Fos expression in OFC is observed (de Costa Araújo et al., 2010).
Also, several studies have found an increase in the rate of discounting following
lesions to OFC (Mobini, Chiang, Ho, Bradshaw, & Szabadi, 2002; Kheramin et
al., 2002, 2004; Rudebeck et al., 2006). However, other studies have observed
either a decrease in discounting (Mar, Walker, Theobald, Eagle, & Robbins,
2011; Winstanley et al., 2004b) or no effect in discounting behavior following
temporary inactivation via GABA agonists or permanent lesions (Abela &
Chudasama, 2013; Churchwell et al., 2009; Jo, Kim, Lee, & Jung, 2013; Mariano
et al., 2009; Stopper, Green, & Floresco, 2014). These discrepancies may result
from differential destruction of subregions of OFC, as lesions to medial OFC
increase sensitivity to delayed reinforcement, whereas lesions to lateral OFC
decrease discounting (Mar et al., 2011).
Other methodogical factors that can potentially explain the discrepancies
observed across studies include baseline levels of impulsive choice and cues
that signal the delay to the larger reinforcer. For example, inactivation of OFC
increases impulsive choice in LoI rats when the delay is signaled, but decreases
impulsivity in HiI rats when the delay is not signaled (Zeeb, Floresco, &
Winstanley, 2010).
Medial prefrontal cortex (mPFC). mPFC can be subdivided into
prelimbic cortex (PrLC) and infralimbic cortex (ILC) and is involved in rewardrelated learning (Balleine & Dickinson, 1998; Richardson & Gratton, 1998).
	
  

16

	
  

mPFC is implicated in the reinforcing effects of drugs of abuse, as well as drug
relapse (see Perry et al., 2011; Tzschentke, 2000 for reviews).
Some studies have shown that mPFC mediates delay discounting. In
humans, decreased impulsive choice is associated with increased thickness in
mPFC (Bernhardt et al., 2014). Also, impulsive choice is negatively correlated
with mPFC activation (Antonelli et al., 2014). In animals, mPFC inactivation
increases sensitivity to delayed reinforcement (Churchwell et al., 2009), although
whole mPFC lesions and ventral mPFC inactivation have no delay-specific
effects on choice between small, immediate and large, delayed rewards
(Cardinal, Pennicott, Sugathapala, Robbins, & Everitt, 2001; Feja & Koch, 2014).
Nucleus accumbens (NAc). NAc is composed of the core (NAcc) and
shell (NAcSh) subregions (Voorn, Gerfen, & Groenewgen, 1989; Zaborsky et al.,
1985) and responds to anticipated rewards (Bjork et al., 2004; Breiter, Aharon,
Kahneman, Dale, & Shizgal, 2001; Francois, Conway, Lowry, Tricklebank, &
Gilmour, 2012; Martin & Ono, 2000; Richardson & Gratton, 2008; Schultz,
Apicella, Scarnati, & Ljungberg, 1992) and mediates the reinforcing effects of
various drugs of abuse (see Chen, Hopf, & Bonci, 2010; Di Chiara, 2002; Di
Chiara et al., 2004; Willuhn, Wanat, Clark, & Phillips, 2010 for reviews). In
general, lesions to NAc attenuate drug self-administration in animals (Corrigall,
Franklin, Coen, & Clarke, 1992; Dworkin, Guerin, Goeders, & Smith, 1988;
Gerrits & Van Ree, 1996).
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Animals performing a delay discounting procedure show an increase in
Fos expression in NAcc (da Costa Araújo et al., 2010). Also, NAcc lesions
increase impulsive choice (Bezzina et al., 2007; Cardinal et al., 2001; da Costa
Araújo et al., 2009; Pothuzien, Jongen-Relo, Feldon, & Yee, 2005; ValenciaTorres et al., 2012; but see Winstanley, Theobald, Dalley, & Robbins, 2005),
whereas combined NAcc/NAcSh lesions increase preference for a large, delayed
reinforcer (Acheson et al., 2006). The findings obtained by Acheson et al. (2006)
do not appear to be the result of damage to NAcSh, as selective lesions to this
subregion do not alter sensitivity to delayed reinforcement (Pothuzien et al.,
2005).
Neurochemical Systems Involved in Impulsive Choice
Several techniques can be used to study the involvement of
neurotransmitter systems in impulsive choice. A common method for
determining the role of a neurotransmitter in discounting behavior is to administer
a drug that acts at specific receptors. Typically, the drug is administered
systemically, although receptor ligands can be directly injected into a brain region
of interest. Another technique that can be used is microdialysis, in which a
neurotransmitter of interest is collected during task performance and later
quantified. Through these techniques, serotonin (5-HT) and dopamine (DA)
systems have been implicated as important mediators of impulsive choice and
will be discussed in detail below.

	
  

18

	
  

Serotonin (5-HT). 5-HT is a monoamine synthesized from tryptophan. 5HT released from a presynaptic neuron can bind to different receptor families,
which are primarily G protein-coupled. Currently, there are 14 known 5-HT
receptor subtypes within 7 different families (see Barnes & Sharp, 1999; Filip &
Bader, 2009 for full reviews). For brevity, only the first three 5-HT receptor
families will be discussed in detail. 5-HT1 receptors can be divided into five
subtypes (5-HT1A,B,D,E,F) which are distributed throughout the brain, particularly in
the raphe nuclei, hippocampus, cerebral cortex, and basal ganglia (Pazos &
Palacios, 1985; Weissmann-Nanopoulos, Mach, Magre, Demassey, & Pujol,
1985; Vergé et al., 1986). 5-HT1 receptors inhibit cyclic adenosine
monophosphate (cAMP; Fargin et al., 1989) and are autoreceptors in the raphe
nuclei and postsynaptic receptors in the limbic system (see Albert, Lembo,
Storring, Charest, & Saucier, 1996; Barnes & Sharp, 1999). 5-HT2 receptors can
be subdivided into three subtypes (5-HT2A-C), and like 5-HT1 receptors, are
distributed throughout the brain, such as hippocampus, cortex, basal ganglia,
amygdala, hypothalamus, and cerebellum (Bonhaus et al., 1995; Pazos, Cortes,
& Palacios, 1985; Pazos, Probst, & Palacios, 1987). 5-HT2 receptors are
coupled to phospholipase C and lead to increased inositol 1,4,5-trisphosphate
and intracellular Ca2+ (Nakaki, Roth, Chuang, & Costa, 1985; Xu & Chuang,
1987). The 5-HT3 receptor is the only 5-HT receptor subtype that is a ligandgated ion channel (Derkach, Surprenant, & North, 1989) and is mainly located in
limbic structures such as the hippocampus and amygdala (Tecott, Maricq, &
Julius, 1993).
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Low 5-HT activity has been linked to impulsive behavior, as individuals
prone to suicide often display impulsive behavior and have decreased levels of
the 5-HT metabolite 5-hydroxyindoleacetic acid (5-HIAA; Åsberg, 1997;
Cremniter et al., 1999; Träskman-Bendz, Åsberg, & Schalling, 1986). Forebrain
5-HT depletion also increases impulsive decision making in humans
(Schweighofer et al., 2008; but see Crean, Richards, & de Wit, 2002) and
animals (Bizot et al., 1999; Mobini et al., 2000; Wogar, Bradshaw, & Szabadi,
1993; but see Winstanley, Dalley, Theobald, & Robbins, 2003, 2004a).
Pharmacological studies also support the role of 5-HT in delay discounting
behavior, although discrepancies are reported in the literature. Inhibiting the
synthesis of 5-HT with para-chlorophenyl-alanine methyl ester increases
impulsive choice in a T-maze paradigm (Denk et al., 2005). The 5-HT indirect
agonist fenfluramine decreases impulsive choice (Poulos, Parker, & Le, 1996),
whereas 5-HT1A receptor agonists dose-dependently promote choice of the
small, immediate reinforcer over the large, delayed reinforcer (Blasio et al., 2012;
Liu, Wilkinson, & Robbins, 2004; Stanis et al., 2008; Winstanley et al., 2005). 5HT1A receptor agonists also decrease choice for the larger reinforcer when the
delay to its delivery is set at 0 sec (Liu et al., 2004; Winstanley et al., 2005); thus,
sensitivity to reinforcer magnitude may be altered, as well as sensitivity to delay.
Stimulating 5-HT2A/C receptors decreases the capacity for rats to wait for
delivery of a large magnitude reinforcer (Blasio et al., 2012; Hadamitzky, Feja,
Becker, & Koch, 2009), whereas antagonism of these receptors does not alter
discounting behavior (Hadamitzky et al., 2009; Paterson, Wetzler, Hackett, &
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Hanania, 2012; Talpos, Wilkinson, & Robbins, 2006). Conversely, antagonism of
5-HT2B/C receptors decreases impulsive choice (Paterson et al., 2012; Talpos et
al., 2006).
There is limited evidence that 5-HT3 receptors are involved in impulsive
choice. Administration of the 5-HT3 receptor antagonist tropisetron decreases
impulsive choice in animals with high baseline levels of impulsivity, whereas
tropisetron increases impulsive choice in animals with low baseline levels of
impulsivity (Cervantes, Biggs, & Delville, 2010).
Stereotaxic techniques show that 5-HT within the mesocorticolimbic
pathway is involved in impulsive decision making. Using in vivo microdialysis,
performance in delay discounting significantly increases 5-HT efflux in mPFC
(Winstanley, Theobald, Dalley, Cardinal, & Robbins, 2006b). Furthermore,
microinjection of 5-HT2A/C receptor antagonists into the OFC increases impulsive
choice (Wischhof, Hollensteiner, & Koch, 2011), whereas 5-HT1A receptor
agonists into the OFC decreases impulsive choice (Yates et al., under review).
Finally, HiI animals have increased 5-HT3 receptor expression in amygdala,
prefrontal cortex (PFC), and NAc (Cervantes, & Delville, 2009). Taken together,
the results of these studies indicate that 5-HT mediates impulsive decision
making.
Dopamine (DA). DA belongs to the catecholamine family and is
synthesized from the amino acid tyrosine. DA released from a presynaptic
neuron can bind to two different types of DA receptors: D1-like and D2-like. D1-
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like receptors (D1 and D5) are located on postsynaptic neurons, are G proteincoupled (Gs), and increase cAMP levels (Dearry et al., 1990; Sunahara et al.,
1991; Tiberi et al., 1991). D1 receptors are primarily located in the striatum, NAc,
cortex, olfactory tubercle, amygdala, and hippocampus (Dearry et al., 1990;
Savasta, Dubois, & Scatton, 1986), whereas D5 receptors are primarily located in
the olfactory tubercle and hippocampus, although these receptors are observed
in other regions, such as striatum, NAc, and cortex (Ciliax et al., 2000; Sunahara
et al., 1991).
Like D1-like receptors, D2-like receptors (D2, D3, and D4) are G proteincoupled (Gi); however, these receptors are located on both presynaptic and
postsynaptic neurons and decrease cAMP when stimulated (Dal Toso et al.,
1989). D2 receptors are primarily located in the striatum, NAc, olfactory tubercle,
amygdala, hippocampus, hypothalamus, ventral tegmental area, and substantia
nigra (Camus, Javoy-Aqid, Dubois, & Scatton, 1986; Charuchinda, Supavilai,
Karobath, & Palacios, 1987). D3 receptors are located in the nucleus
accumbens, hypothalamus, and olfactory tubercle (Bouthenet et al., 1991;
Sokoloff, Giros, Martres, Bouthenet, Schwartz, 1990). D4 receptors are located
in the cortex, amygdala, hypothalamus, hippocampus, and substantia nigra
(O’Malley, Harmon, Tang, & Todd, 1992; Wedzony, Chocyk, Maćkowiak, Fijał, &
Czyrak, 2000).
The role of DA in delay discounting is of particular interest because many
drugs of abuse, as well as medications used to treat impulse-control disorders
(e.g., ADHD; see Biederman & Faraone, 2005 for a review), increase
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extracellular DA levels (Caillé & Parsons, 2003; Creese & Iverson, 1975; Jones,
Gainetinov, Wightman, & Caron, 1998; Kuczenski & Segal, 1997; Moghaddam &
Bunney, 1989; Volkow, Fowler, Wang, Ding, & Gatley, 2002). As expected,
psychostimulant medications such as amphetamine and methylphenidate
decrease impulsive choice (e.g., Broos et al., 2012a; Cardinal, Robbins, &
Everitt, 2000; de Wit et al., 2002; Pitts & McKinney, 2005; van Gaalen, van
Koten, Schoffelmeer, & Vanderschuren, 2006b; Winstanley et al., 2003).
Based on the findings observed with ADHD medications, drugs that
stimulate DA neurotransmission should decrease impulsive choice, whereas
drugs that inhibit DA release should increase impulsive choice. More specifically,
drugs that stimulate postsynaptic D1-like receptors or inhibit presynaptic D2-like
receptors should decrease impulsivity, whereas inhibiton of D1-like receptors and
stimulation of D2-like autoreceptors should increase impulsivity. There is some
support for this hypothesis, as systemic administration of the nonselective DA
receptor antagonist flupenthixol (Cardinal et al., 2000; Floresco, Tse, & GhodsSharifi, 2008; Wade, de Wit, & Richards, 2000), as well as selective antagonism
of D1 receptors promote impulsive choice (Broos et al., 2012a; Koffarnus,
Newman, Grundt, Rice, & Woods, 2011; van Gaalen et al., 2006b; but see Wade
et al., 2000). However, contrary to the hypothesis that DA stimulation decreases
impulsive choice, systemic administration of D1-like receptor agonists do not
alter delay discounting (Koffarnus et al., 2011).
Research examining the role of DA D2-like receptors has yielded mixed
results. A couple of reports found increases in impulsive choice following
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antagonism of D2-like receptors (Denk et al., 2005; Wade et al., 2000), whereas
others did not observe changes in delay discounting (Evenden & Ryan, 1996;
Koffanus et al., 2011; van Gaalen et al., 2006b). Considering that D2-like
receptors are composed of three subtypes, perhaps D3 and D4 receptors have a
more specific role in mediating impulsive decision making. Administration of the
D3 agonist 7-OH-DPAT and the D4 partial agonist ABT-724 increase delay
discounting (Koffarnus et al., 2011; van den Bergh, Bloemarts, Groenink, Olivier,
& Oosting, 2006). However, it is important to note that administration of D3
receptor agonists do not necessarily affect sensitivity to delayed reinforcement,
as choice for the large reinforcer decreases when its delivery is immediate
(Koffarnus et al., 2011; Madden, Johnson, Brewer, Pinkston, & Fowler, 2010; van
den Bergh et al., 2006).
DA activity specifically in prefrontal cortical regions has been associated
with impulsive choice. Using microdialysis, an increase in intra-OFC 3,4-dihydroxyl-phenylacetic acid (DOPAC) is observed in rats performing a delay
discounting task (Winstanley et al., 2006b). HiI rats show reduced DA release in
mPFC and NAc relative to LoI rats (Diergaarde et al., 2008). Depleting DA levels
in mPFC also increases impulsive decision making (Loos et al., 2010; Pardey et
al., 2013), and overexpression of the DA transporter (DAT) gene in NAc is
associated with increased impulsive choice (Adriani et al., 2009). As with
systemic drug administration, one unexpected finding is that antagonism of DA
D2-like receptors within OFC and mPFC increases impulsive choice (Pardey,
Kumar, Goodchild, & Cornish, 2013; Yates et al., under review; Zeeb et al., 2010)
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and administration of a D1-like agonist into mPFC increases impulsive choice
(Loos et al., 2010). Thus, while some inconsistencies exist, results overall
suggest that decreased DA levels is associated with increased impulsive choice.
In addition to DA specifically, Winstanley et al. (2005) argue that 5-HT and
DA interactions within NAc contribute to impulsive decision making. For
example, the 5-HT1A agonist 8-OH-DPAT decreases choice for a large, delayed
reinforcer; however, this effect is not observed in rats with intra-NAc 6hydroxydopamine lesions (Winstanley et al., 2005). The results obtained by
Winstanley et al. (2005) are difficult to interpret because 8-OH-DPAT decreases
choice for the large reinforcer when its delivery is not delayed. Therefore, DA
and 5-HT interactions within NAc may be important for discriminating reinforcers
of differing magnitudes, as opposed to discriminating delays to reinforcement.
Although 5-HT and DA have received considerable attention in delay
discounting research, there is evidence that other neurotransmitter systems are
important in mediating impulsive decision making, including norepinephrine
(Robinson et al., 2008; van Gaalen et al., 2006b), acetylcholine (specifically
muscarinic receptors; Mendez, Gilbert, Bizon, & Setlow, 2012), opioid peptides
(Pattij, Schetters, Janssen, Wiskerke, & Schoffelmeer, 2009; Schippers et al.,
2012), and glutamate (Glu; Cottone et al., 2013; Floresco et al., 2008; Sukhotina
et al., 2008). Thus, multiple neurotransmitter systems working in an interactive
fashion are involved in impulsive choice.
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Glutamate (Glu). Glu is the major excitatory neurotransmitter in the
mammalian brain and acts at both metabotropic (mGluR, G protein-coupled) and
ionotropic receptors (iGluR, ion channel-coupled; see Ozawa, Kamiya, &
Tsuzuki, 1998 for a review). mGluRs can be subdivided into three classes: group
I mGluRs consists of mGluR1 and mGluR5, which are located on postsynaptic
terminals and are stimulatory; in contrast, group II and group III mGluRs consist
of mGluR2-8, which are mainly presynaptic and are inhibitory (Ozawa et al.,
1998; Riedel, Platt, & Micheau, 2003). Like mGluRs, iGluRs can be subdivided
into three groups: α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA),
kainate, and N-methyl-D-aspartate (NMDA), which are discussed in more detail
below.
AMPA receptors are tetramers composed of four subunits (GluR1-4) and
are found ubiquitously throughout the brain, with high levels observed in the CA1
and CA3 regions of the hippocampus, as well as cerebral cortex, basal ganglia,
thalamus, hypothalamus, cerebellum, and spinal cord (Blackstone et al., 1992;
Dure & Young, 1995; see Ozawa et al., 1998; Riedel et al., 2003 for reviews).
Activation of AMPA receptors increases Na+ and Ca2+ influx and K+ efflux (see
Forman, Chou, Strichartz, & Lo, 2008 for a discussion), and these receptors are
responsible for the fast, immediate postsynaptic response to glutamate release
(see Riedel et al., 2003). Like AMPA receptors, kainate receptors are tetramers
composed of various subunits (GluR5-7 and KA1-2), with high levels located in
the CA3 region of the hippocampus and in the cerebellum (see Ozawa et al.,
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1998). Because dissociating AMPA and kainate receptors can be difficult, these
receptors are often labeled as “non-NMDA” receptors (see Riedel et al., 2003).
NMDA receptors are heteromeric complexes with the NR1 as the primary
constitutive subunit and NR2 (A-D) as functional subunits that affect channel
kinetics and sensitivity (Mori & Mishina, 1995). Individual subunits are trafficked
to synapses and can be substituted with one another. For example, NR2Bcontaining receptors can be replaced by NR2A-containing receptors (Barria &
Malinow, 2002). Like non-NMDA receptors, NMDA receptors are found
throughout the brain, with the highest concentrations observed in the CA1 region
of the hippocampus, thalamus, and cerebral cortex (see Ozawa et al., 1998;
Riedel et al., 2003). The NMDA receptor channel will open following voltage
dependent removal of a Mg2+ ion (Novak Bregestovski, Ascher, Herbet, &
Prochiantz, 1994), glycine binding to the NR1 subunit, and binding of Glu or
NMDA receptor agonist to the NR2 subunit (see Lynch & Guttmann, 2001;
Ozawa et al., 1998 for reviews). Once the channel opens, Na+ and Ca2+ are able
to enter the neuron, and there is an increase in K+ efflux (see Riedel et al., 2003).
There is evidence that the glutamatergic system interacts with monoamine
neurotransmitters. Stimulation of 5-HT1 receptors inhibits Glu release (Choi,
Cho, & Jang, 2013; Guo & Rainnie, 2010; Mauler, Fahrig, Horváth, & Jork, 2001).
Furthermore, there is evidence that 5-HT1B and 5-HT1D receptors are
heteroreceptors on glutamate neurons, which control the release of Glu (see
Sari, 2013 for a discussion). There is speculation that 5-HT2A regulates
presynaptic release of Glu. For example, lysergic acid diethylamide (LSD)
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increases Glu levels in PFC, an effect that is blocked by a selective 5-HT2A
antagonist (Muschamp, Regina, Hull, Winter, & Rabin, 2004). Glu is proposed to
modulate the release of DA, as stimulation of NMDA receptors within PFC
decreases DA release in the same region (Del Arco & Mora, 2001).
Furthermore, antagonism of NMDA receptors within PFC increases DA levels
within NAc (Del Arco, Segovia, & Mora, 2008).
Glutamatergic activity is important in learning (see Riedel et al., 2003 for a
comprehensive review), and is hypothesized to be abnormal in several
psychiatric conditions, including ADHD (MacMaster, Carrey, Sparkes, &
Kusumakar, 2003). Also, evidence suggests a role for Glu in the initiation,
maintenance, and relapse of abuse-related behaviors (see Kalivas, 2009 for a
review).
Some evidence suggests a role for Glu in impulsive choice. Antagonism
of mGluR1 receptors decreases sensitivity to delayed reinforcement (Sukhotina
et al., 2008). Furthermore, administration of the mGluR2/3 receptor agonist
LY379268 attenuates 5-HT2A-induced impulsive choice, although administration
of LY379268 alone does not alter discounting (Wischof et al., 2011). Blockade of
NMDA receptors with the noncompetitive antagonists ketamine and/or
memantine increase impulsive choice (Cottone et al., 2013; Floresco et al., 2008;
but see Oberlin, Bristow, Heighton, & Grahame, 2010). However, interpreting the
results obtained by Cottone et al. (2013) and Floresco et al. (2008) is difficult
because ketamine and memantine inhibit 5-HT receptors (Kapur & Seeman,
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2002; Rammes, Rupprecht, Ferrari, Zieglgänsberger, & Parsons, 2001). Overall,
more work is needed to elucidate the role of Glu in impulsive choice.
Overview of the Current Experiments
Due to the complexity of impulsive decision making, there is a need to
elucidate the underlying neuromechanisms of this facet of impulsivity.
Understanding the precise role of Glu and DA in this behavior may shed light as
to why increased impulsive choice is a predictor and consequence of substance
use disorders. Although NAcc is consistently shown to mediate impulsivity, it is
unclear which neurotransmitters within this region are involved in discounting.
Thus, the overall goal of the current experiments was to elucidate the role of
NAcc glutamatergic and dopaminergic systems in mediating impulsive choice.
Studies using systemic drug administration have examined the role of DA
receptors in discounting performance. Although there are some discrepancies,
findings generally support the hypothesis that increasing DA levels decreases
impulsive decision making. However, the role of Glu in delay discounting is not
as clear. Therefore, Experiment 1 was conducted to further clarify the role of
ionotropic Glu receptors in impulsive decision making. The effects of the
noncompetitive NMDA channel blocker MK-801 and the AMPA receptor
antagonist 6-cyano-7-nitroquinoxaline-2,3-dione disodium salt hydrate (CNQX)
on delay discounting performance were examined. It was hypothesized that
blocking NMDA and AMPA receptors would increase impulsive choice.
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Experiment 2 was conducted to determine if NMDA receptor and
dopamine transporter expression differed in HiI and LoI animals. DAT was
selected because drugs used to treat impulse control disorders exert their
therapeutic effects by blocking DAT (see Biederman & Faraone, 2005 for a
review). The hypothesis was that high impulsive animals would have decreased
NMDA receptor, but increased DAT, expression within NAcc relative to low
impulsive animals.
The goal of Experiment 3 was to determine the role of NAcc NMDA and
DA receptors in mediating impulsive choice. Furthermore, the goal was to
determine if NR2B containing NMDA receptors are important for controlling
impulsive choice. One group of rats received intra-NAcc bilateral infusions of the
Glu-selective ligands MK-801, AP-5 (NMDA competitive antagonist), ifenprodil
(NR2B antagonist), and CNQX. Another group of rats received the DA D1-like
ligands SKF 38393 (agonist) and SCH 23390 (antagonist) and the DA D2-like
ligands quinpirole (agonist) and eticlopride (antagonist). There were two major
hypotheses. First, antagonism of NMDA receptors, specifically NR2B containing
receptors, would decrease impulsive choice. Second, antagonism of D1-like and
D2-like receptors would increase impulsive choice.

Copyright © Justin Ryan Yates 2014
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Chapter 2: Experiment 1
Introduction
Although evidence shows that 5-HT and DA receptors are involved in
impulsive choice (e.g., Cardinal et al., 2000; Floresco et al., 2008; Koffarnus et
al., 2011; Liu et al., 2004; van Gaalen et al., 2006b; Winstanley et al., 2005), the
specific role of iGluRs in this task is unknown. Some evidence suggests that
blockade of NMDA receptors with the noncompetitive antagonists ketamine and
memantine increase impulsive choice (Cottone et al., 2013; Floresco et al.,
2008). However, ketamine and memantine interact with 5-HT receptors (Kapur &
Seeman, 2002; Rammes et al., 2001), thus complicating the results of these
studies. This study was performed to further clarify the role of NMDA receptors
in impulsive choice by testing the effects of the noncompetitive NMDA receptor
antagonist MK-801 in delay discounting. To determine the potential role of
AMPA receptors in delay discounting, a subset of rats were treated with the
AMPA receptor antagonist CNQX.
Materials and Methods
Animals
Twelve male Sprague Dawley rats were obtained from Harlan Industries
(Indianapolis, IN). They were acclimated to a colony room held at a constant
temperature and handled for 5 days upon arrival. Rats had no prior operant
training before the current experiment; however some were treated with
amphetamine (1.0 mg/kg; 4 injections) or saline (4 or 8 injections) during
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adolescence in a previous experiment. Amphetamine treatment during
adolescence did not significantly alter discounting of delayed or probabilistic
reinforcement in the current study (data not shown). Rats were individually
housed during the current experiment. Light and dark phases were on a 12:12 h
cycle, and all experiments occurred in the light phase. Rats were food restricted
(approximately 80% of free feed body weight) during behavioral studies. All
procedures were in accordance with the “Guide for the Care and Use of
Laboratory Animals” (National Research Council, 2011) and were approved by
the Institutional Animal Care and Use Committee at the University of Kentucky.
Drugs
(+)-MK-801 hydrogen maleate and 6-cyano-7-nitroquinoxaline-2,3-dione
disodium salt hydrate (Sigma, St. Louis, MO) were prepared in sterile 0.9% NaCl
(saline) and subcutaneously injected in a volume of 1 ml/kg. The doses were
calculated based on salt weight.
Apparatus
Operant conditioning chambers (28 × 21 × 21 cm; ENV-008; MED
Associates, St. Albans, VT) located inside sound-attenuating chambers (ENV018M; MED Associates) were used. The front and back walls of the
experimental chambers were made of aluminum, while the side walls were made
of Plexiglas. There was a recessed food tray (5 x 4.2 cm) located 2 cm above
the floor in the bottom-center of the front wall. An infrared photobeam was used
to record headentries into the food tray. A 28-V white cue light was located 6 cm
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above each response lever. A white houselight was mounted in the center of the
back wall of the chamber. All responses and scheduled consequences were
recorded and controlled by a computer interface. A computer controlled the
experimental session using Med-IV software.
Procedure
Rats were given 2 days of magazine training, in which sucrose-based 45
mg pellets (F0021 dustless precision pellet, Bio-Serve, Frenchtown, NJ) were
noncontingently delivered into the food tray. These sessions were used to
habituate rats to the operant chamber. Following magazine training, rats were
given lever press training. Each session began with illumination of the
houselight. A head entry into the food hopper resulted in presentation of one
lever. Levers were presented semi-randomly, with no more than two consecutive
presentations of the same lever. A response on either lever resulted in delivery
of one sucrose pellet. Pellets were also delivered noncontingently on a random
time 100-sec schedule of reinforcement. Following a response on either lever,
the houselight was extinguished, and the lever was retracted for 5 sec. After 5
sec, the houselight was illuminated. Each session lasted 30 min.
After 3 sessions, rats received reward magnitude discrimination training,
which consisted of 40 trials. Each trial lasted 40 sec and began with illumination
of the houselight. A headentry into the food hopper extended one of the levers
(semi-randomly presented, with no more than two consecutive presentations of
the same lever). A response on one lever resulted in immediate delivery of one
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pellet, whereas a response on the other lever resulted in immediate delivery of
four pellets (the lever associated with the large reward magnitude was
counterbalanced across rats). Following a response, the houselight was
extinguished, and the lever was retracted for the remainder of the trial. If a
response was not made within 10 sec, the trial was scored as an omission, and
the houselight was extinguished for the remainder of the trial. After 7 days of
reward magnitude discrimination training, rats were trained in a delay discounting
task.
Delay discounting sessions consisted of 5 blocks of 9 trials, and each trial
lasted 60 sec. The first 4 trials in a block were forced-choice trials, in which only
one lever was semi-randomly presented (no more than 2 consecutive
presentations of the same lever). The last 5 trials were free-choice trials, in
which both levers were extended. As in reward magnitude discrimination
training, a response on one lever always resulted in immediate delivery of one
food pellet. A response on the other lever resulted in delivery of 4 pellets;
however, the delay to the delivery of the large magnitude reward increased
across blocks of trials (0, 5, 10, 20, 50 sec). Following a response on either
lever, the houselight was extinguished, and the lever was retracted for the
remainder of the trial. If a response was not made within 10 sec, the trial was
scored as an omission, and the houselight was extinguished for the remainder of
the trial.
After training, rats received various doses of the NMDA receptor
antagonist MK-801 (0, 0.01, 0.03, 0.1, or 0.3 mg/kg, s.c.) 15 min prior to the
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session. The doses and pretreatment time were chosen based on previous work
(Almasi-Nasrabadi et al., 2012; Fredriksson & Archer, 2002; Wooters, Dwoskin,
& Bardo, 2011). A subset of rats (n = 6) received additional training in the delay
discounting task before receiving various doses of the AMPA receptor antagonist
CNQX (0, 1, 3, or 5.6 mg/kg, i.p.) 20 min prior to the session. The doses and
pretreatment time were chosen based on previous work (Bäckström & Hyytiä,
2004; Wooters et al., 2011). In each experiment, pretreatments occurred once
every 4 days, and dose order was randomized.
Statistical Analyses
To determine if MK-801 or CNQX altered delay discounting, two analyses
were used. First, the hyperbolic discounting function was used and was defined
with the equation V = A/(1+kX), where V is the subjective value of the reinforcer,
A is reinforcer amount, k is the rate of discounting, and X represents the delay to
reinforcer delivery (Mazur, 1987). Second, area under the curve (AUC) was
calculated as previously described (Myerson et al., 2001). The delay and
subjective value for each data point were first normalized. Delay was expressed
as a proportion of the maximum delay, and the subjective value was expressed
as a proportion of the nominal amount. These normalized values were used as x
coordinates and y coordinates, respectively, to construct a graph of the
discounting data. Vertical lines were drawn from each data point to the x axis,
subdividing the graph into a series of trapezoids. The area of each trapezoid is
equal to (x2 – x1)[(y1 + y2)/2], where x1 and x2 are successive delays, and y1 and
y2 are the subjective values associated with these delays. The area under the
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discounting function is equal to the sum of the areas of these trapezoids. AUC
values range from 0 to 1, with values closer to 0 indicating steeper discounting
and values closer to 1 representing shallower discounting.
K parameter estimates (log transformed) and AUCs were analyzed with
repeated measures analyses of variance (ANOVA), with treatment as a withinsubjects factor. Main effects were probed with Bonferroni post hoc tests.
Cohen’s f was calculated as a measure of effect size, with 0.10, 0.25, and 0.40
defined as small, medium, and large, respectively (Cohen, 1988). Because
omissions and A parameter estimates were not normally distributed, these data
were analyzed with Friedman tests. Main effects were probed with Wilcoxon
signed-ranked post hoc tests. Startisitical significance was defined as p < .05 in
all cases, except for the use of Wilcoxon signed-ranked post hoc test, in which a
Bonferroni adjustment was used to correct for multiple comparisons.
Results
Figure 2.1 shows the proportion of choices for the delayed reinforcer
following all doses of MK-801 (Figure 2.1A) and CNQX (Figure 2.1B). The
proportion of choices for the large delayed reinforcer decreased as function of
the delay to receiving reinforcement, although the highest doses of MK-801 (0.1
and 0.3 mg/kg) flattened the discounting function. The flattening of the
discounting function following MK-801 (0.1 and 0.3 mg/kg) can be attributed to a
loss in schedule control, as these doses significantly increased omissions (χ2(2) =
41.02, p < .05; Figure 2.2A). The highest dose of MK-801 (0.3 mg/kg) disrupted
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behavior across all blocks of trials, whereas the 0.1 mg/kg dose suppressed
behavior in the first three blocks of delay discounting (data not shown). Because
the higher doses of MK-801 produced a general suppression in behavior,
hyperbolic discounting functions could not be generated for all animals; thus,
these doses were excluded from subsequent analyses of parameters A and k, as
well as AUC. CNQX did not significantly alter omissions (Figure 2.2B), so each
dose (1, 3, 5.6 mg/kg) was included in all subsequent analyses.
Parameters k and A were derived and plotted in Figure 2.3 and Figure 2.4,
respectively, for each drug dose, except for the two highest doses of MK-801 (0.1
and 0.3 mg/kg). MK-801 (0.03 mg/kg) decreased sensitivity to delayed
reinforcement (F(2, 22) = 5.04, p < .05, Cohen’s f = .67; Figure 2.3A). The
overall nonparametric analysis indicated that MK-801 also increased sensitivity to
reinforcer magnitude in the delay discounting task (χ2(2) = 7.64, p < .05);
however, post hoc tests revealed no significant differences between doses (p’s >
.025, Bonferroni correction; Figure 2.4A). CNQX did not alter sensitivity to
delayed reinforcement (Figure 2.3B) or reinforcer magnitude (Figure 2.4B).
Figure 2.5 shows AUCs for each drug dose, except for the highest dose of
MK-801 (0.3 mg/kg; this dose was excluded because AUCs were virtually 0 for
all animals). Repeated measures ANOVA revealed that MK-801 (0.03 mg/kg)
significantly increased AUCs (F(2, 22) = 6.35, p < .01, Cohen’s f = .77; Figure
2.5A), whereas CNQX did not significantly alter AUCs (Figure 2.5B).
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Discussion
There were two important findings from the current experiment. First,
NMDA receptor blockade with MK-801 dose-dependently decreased sensitivity to
delayed reinforcement. The decrease in sensitivity occurred at a dose of MK-801
(0.03 mg/kg) that did not alter omissions, suggesting a specific effect on choice
behavior. Second, AMPA receptor blockade did not alter sensitivity to delayed
reinforcement. Together, these results demonstrate a differential involvement of
NMDA and AMPA receptors in delay discounting, with NMDA receptors playing a
more critical role.
The current results show that the non-competitive NMDA receptor
antagonist MK-801 decreases sensitivity to delayed reinforcement (k parameter).
This finding contrasts with previous studies showing that the non-competitive
antagonists ketamine and memantine increase delay discounting (Cottone et al.
2013; Floresco et al. 2008). However, in addition to the different NMDA
antagonists used, a number of methodological differences exist which prevent
direct comparisons across studies. For example, in contrast to the current study,
Cottone et al. (2013) used an adjusting delay procedure, whereas the current
study used a progressive discounting procedure derived from Evenden and Ryan
(1996). Interpreting results from the adjusting delay procedure used by Cottone
et al. (2013) is difficult because the dependent variable confounds sensitivity to
delayed reinforcement and reinforcer magnitude, which are proposed to
independently influence discounting of a reinforcer (Ho, Mobini, Chiang,
Bradshaw, & Szabadi, 1999). Additionally, there is evidence to suggest that
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animals trained in an adjusting delay procedure may not be sensitive to the
adjusting delay to reinforcement (Cardinal et al., 2002). Although Floresco et al.
(2008) used a similar discounting procedure as the current study, a maximum
delay of 6.5 sec was imposed, which is considerably shorter than the maximum
delay used in the current study (50 sec). Importantly, ketamine administration
produced a parallel negative shift in the discounting curve at each delay,
suggesting that sensitivity to reinforcer magnitude, but not the rate of discounting,
was altered. Future studies employing discounting functions may be better
suited to determine the effect of various drug treatments on sensitivity to
reinforcer amount and/or sensitivity to delayed reinforcement within discounting
tasks.
Beyond these methodological differences, an important pharmacological
consideration for comparing results across studies is that MK-801, ketamine, and
memantine show differential selectivity for non-NMDA receptors. For example, in
contrast to MK-801, ketamine acts at sigma receptors (Robson, Elliott,
Seminerio, & Matsumoto, 2012) and opioid receptors (Gupta, Devi, & Gomes,
2011). Similarly, in contrast to MK-801, memantine reduces the physical signs of
opiate withdrawal (Maldonado, Cauli, Rodriguez-Arias, Aguilar, & Minarro, 2003).
Ketamine also acts as an antagonist at 5-HT2 receptors (Kapur & Seeman,
2002), and memantine blocks 5-HT3 receptors (Rammes et al., 2001), although
antagonism of 5-HT receptors typically does not increase the rate of discounting
(Hadamitzky et al., 2009; Liu et al., 2004; Talpos et al., 2006). MK-801 also has
non-NMDA activity, as it inhibits nicotinic acetylcholine receptors (Amador &
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Dani, 1991; Briggs & McKenna, 1996); however, blockade of nicotinic receptors
does not alter discounting of delayed reinforcement (Mendez et al., 2012).
Another important consideration is that memantine and MK-801 block
NMDA receptor channels in different ways and show differential affinity for
synaptic and extrasynaptic NMDA receptors. Specificially, memantine reduces
NMDA receptor-mediated excitatory postsynaptic potentials in a voltagedependent manner, whereas the effects of MK-801 on postsynaptic potentials
appear to be less voltage-dependent (Frankiewicz, Potier, Bashir, Collingridge, &
Parsons, 1996). Furthermore, memantine shows fast blocking and unblocking
kinetics, whereas MK-801 shows slow blocking and unblocking kinetics (see
Danysz, Parsons, Kornhuber, Schmidt, & Quack, 1997 for a review). Finally,
memantine preferentially blocks extrasynaptic NMDA receptors, whereas MK801 blocks extrasynaptic and synaptic NMDA receptors (Xia et al., 2010). Thus,
the different pharmacological profiles of memantine and MK-801 may account for
the differential effects observed in delay discounting.
As for DA activity, previous work has shown that acute administration of
MK-801 (0.03 and 0.1 mg/kg) increases DA levels in PFC (Tsukada et al., 2005).
Interestingly, drugs that increase DA levels typically decrease sensitivity to
delayed reinforcement (Broos et al., 2012a; Cardinal et al., 2000; de Wit et al.,
2002; Pitts & McKinney, 2005; van Gaalen et al., 2006b; Winstanley et al., 2003).
Thus, the decrease in discounting observed following MK-801 administration
might be explained from its interaction with the prefrontal DA system.
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Interpreting AUCs can be problematic because this measure does not
take into consideration sensitivity to reinforcer magnitude. For example, AUCs
for MK-801 (0.1 mg/kg) and vehicle did not differ significantly, which might
suggest that MK-801 did not alter task performance at this dose. However, 0.1
mg/kg MK-801 flattened the discounting curve, demonstrating a general
disruption in task performance at the 0 sec delay. Overall, these results show
that AUCs do not always describe discounting performance accurately when
sensitivity to reinforcer magnitude is altered.
In conclusion, results from the current study show that NMDA and AMPA
receptors differentially mediate discounting of delayed reinforcement. Blockade
of NMDA receptors with the non-competitive antagonist MK-801 decreased
sensitivity to delayed reinforcement, whereas antagonism of AMPA receptors
with CNQX did not alter delay discounting. Understanding the precise role of
glutamate systems might be beneficial in developing treatments for disorders
characterized by increased impulsivity, such as drug abuse.
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Figure 2.1. Mean (± SEM) proportion of choices for the large magnitude
reinforcer as a function of the delay to receiving reinforcement following
pretreatments with MK-801 (Panel A) and CNQX (Panel B).
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Figure 2.2. Mean (± SEM) omissions during free-choice trials following
pretreatments with MK-801 (A) and CNQX (B). *p < .05, relative to vehicle.
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Figure 2.3. Mean (± SEM) parameter estimate k values (log transformed)
following pretreatments with MK-801 (A) and CNQX (B). *p < .05, relative to
vehicle.
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Figure 2.4. Mean (± SEM) parameter estimate A values following pretreatments
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Figure 2.5. Mean (± SEM) area under the curve (AUC) values following
pretreatments with MK-801 (A) and CNQX (B). *p < .05, relative to vehicle. Note
that MK-801 (0.1 mg/kg) is not connected to the line in the graph because this
dose was not used in analyses due to the large increase in omissions.
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Chapter 3: Experiment 2
Introduction
The results from Experiment 1 showed that blockade of NMDA receptors
with MK-801 decreased impulsive choice. However, it is unknown if NMDA
receptor densities are altered in animals that show differential sensitivity to
delayed reinforcement. Therefore, the goal of the present experiment was to use
in vitro receptor autoradiography to quantify NMDA receptor density in the NAcc.
This region was chosen because it has been consistently shown to be involved in
impulsive choice (Bezzina et al., 2007; Cardinal et al., 2001; da Costa Araújo et
al., 2009; Valencia-Torres et al., 2012), and NAcc NMDA receptors play a critical
role in addiction (see Kalivas, 2009 for a review). Because damage to the
NAcSh does not alter delay discounting (Pothuzien et al., 2005), this region was
examined as a negative control.
A secondary goal of the present experiment was to determine if DAT is
altered in HiI and LoI impulsive rats. DAT was also examined because
psychostimulant medications exert their therapeutic effects by blocking DAT (see
Biederman & Faraone, 2005 for a review). Furthermore, there is evidence that
overexpression of DAT within NAc leads to increased impulsive decision making
in a delay discounting task (Adriani et al., 2009). The hypothesis for this
experiment was that HiI animals would have decreased NMDA receptor, but
increased DAT, expression within NAcc relative to LoI animals.
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Materials and Methods
Animals
A total of 24 experimentally naïve (i.e., have not received any
pharmacological treatments) male, Sprague Dawley rats were obtained from
Harlan Industries (Indianapolis, IN). Rats weighed approximately 250-275 g
upon arrival to the laboratory and were housed individually. Rats were
acclimated to a colony room held at a constant temperature and were handled for
5 days upon arrival. Light and dark phases were on a 12:12 h cycle, and all
experiments occurred during the light phase. Rats were food restricted
(approximately 80% of free feed body weight) 3 days before the beginning of
behavioral training, and rats remained on food restriction during the remainder of
the study, unless otherwise noted.
Apparatus
The apparatus was the same as described in Experiment 1.
Procedure
Pre-training was similar to the training described in Experiment 1, with one
exception. During the initial lever press training, sessions ended after 30 min or
following 40 trials (20 trials for each lever), whichever occurred first. The
magnitude discrimination and delay discounting sessions were conducted as
described in Experiment 1.
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Following 28 sessions of delay discounting, rats were killed, and brains
were removed and flash-frozen in chromasolv (Sigma Aldrich; St. Louis, MO) on
dry ice and stored at -80°C until sectioning was completed. Coronal brain
sections (16 µm) were taken and used for in vitro receptor autoradiography.
For NMDA receptor autoradiography, sections were first preincubated for
30 min at room temperature (RT) in buffer containing 5 mM Tris HCL and 2.5 mM
CaCl2 (pH 7.4), then incubated for 90 min at room RT in fresh buffer containing
10 nM [3H]MK-801, 5 µM glutamic acid, 100 µM glycine, and 5 µM spermidine.
After incubation, slides were washed three times in ice cold 5 mM Tris-HCl buffer
for 20 min, followed by one wash in 0.5 mM Tris-HCl buffer and one wash in
double distilled water. Slides were air dried and stored overnight before filming.
Slides containing the brain sections were placed into a light-proof cassette and
exposed to Kodak film. Films were developed following 6 weeks of exposure.
For DAT autoradiography, sections were preincubated for 15 min at RT in
buffer containing 50 mM Tris-HCL, 120 mM NaCl, and 5 mM KCl (pH 7.4), then
incubated for 120 min in fresh buffer containing 50 pM [125I]-RTI-121, 120 mM
NaCl, 5 mM KCl, .001% ascorbic acid, .025% BSA, and 1 µM fluoxetine. After
incubation, slides were washed four times in ice cold 50 mM Tris-HCl buffer for
30 min, followed by one wash in 5 mM Tris-HCl buffer and one wash in double
distilled water. Slides were air dried and stored overnight before filming. Slides
containing the brain sections were placed into a light-proof cassette and exposed
to Kodak film. Films were developed following 3 days of exposure.
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For NMDA receptor and DAT autoradiography, [3H]-MK-801 and [125I]-RTI121 binding data were analyzed with Image J (http://imagej.nih.gov/ij). NAcc and
NAcSh in each hemisphere were outlined manually, and mean binding density
was calculated for each individual animal (4-6 coronal sections were analyzed for
each animal). Binding densities in the left and right hemisphere were averaged to
form one value for each animal.
Statistical Analyses
For the autoradiography experiment, only the top third of impulsive rats
(HiI; n =8) and bottom third of impulsive rats (LoI; n = 7; one brain for a LoI rat
was destroyed during extraction) were used in data analysis. To ensure that
discounting in rats selected as HiI and LoI was different, parameter estimates k
(log transformed; note: there were a couple of instances in which an animal
chose the large magnitude reinforcer every single free-choice trial; therefore,
their log-transformed k value had to be arbitrarily set at -5.0) and A were
analyzed with a mixed-factor ANOVA, with session block (7 levels; 7 4-day
blocks) as a within-subjects factor and impulsivity (HiI vs. LoI) as a betweensubjects factor (note: separate ANOVAs were conducted for k and A).
For NMDA receptor and DAT binding, mean [3H]-MK-801 and [125I]-RTI121 binding densities in the NAcc and NAcSh were compared between HiI and
LoI rats with independent-samples t tests. Statistical significance was set at p <
.05 in all cases.
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Results
Figure 3.1 shows discounting performance in HiI and LoI rats at different
time points during training. During training, the proportion of choices for the
large, delayed reinforcer decreased as a function of delay for both HiI and LoI
rats, although HiI rats responded less for the large magnitude reinforcer relative
to LoI rats as the delay to its delivery increased. Figure 3.2 shows parameter
estimates of k (log transformed) and A in HiI and LoI rats across 4-day blocks.
For k (log transformed) parameter estimates, results from the mixed-factor
ANOVA indicated main effects of session block (F(6, 84) = 6.96, p < .05, ηp2 =
.33) and impulsivity (F(1, 14) = 12.79, p < .05, ηp2 = .48). The session block ×
impulsivity interaction approached statistical significance (F(6, 84) = 2.17, p =
.054, ηp2 = .13). These results show that across training, both HiI and LoI rats
became more sensitive to delay; however, HiI rats showed greater sensitivity to
delay reinforcement relative to LoI across training (Figure 3.2A). For A
parameter estimates, results from the mixed-factor ANOVAs revealed a main
effect of impulsivity (F(1, 14) = 4.80, p < .05, ηp2 = .26; Figure 3.2B). Overall, HiI
rats were less sensitive to reinforcer magnitude relative to LoI rats. This
difference was most pronounced during the first three session blocks. A
separate Mann-Whitney t test was conducted to compare A parameter estimates
in HiI and LoI rats during the final block of sessions. Results from the t test
revealed no differences in sensitivity to reinforcer magnitude.
Figure 3.3 shows a schematic of the NAcc and NAcSh, and Figure 3.4
shows representative autoradiograms for [3H]-MK-801 (Panel A) and [125I]-RTI	
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121 binding (Panel B). For NMDA receptor binding (Figure 3.5A), there were no
differences between HiI and LoI rats in NMDA receptor binding within NAcc or
NAcSh.
For DAT binding (Figure 3.5B), there were no differences between HiI and LoI
rats in DAT binding within NAcc or NAcSh.
Discussion
In the current experiment, there were no statistically significant differences
in NMDA receptor or DAT expression in HiI and LoI rats. Overall, these results
suggest that differences in delay discounting do not result from baseline
differences in NAc NMDA receptor or DAT expression.
There is a growing interest in the role of Glu, particularly the NMDA
receptor, in impulse control disorders such as attention deficit hyperactivity
disorder (ADHD; see Chang, Lane, & Tsai, in press for a recent review). A
recent pilot study showed that the noncompetitive NMDA receptor antagonist
memantine is efficacious in reducing the inattentive and hyperactivity subtypes of
ADHD (Surman et al., 2013). Also, atomoxetine, a norepinephrine reuptake
inhibitor, acts as an NMDA receptor antagonist at clinically relevant
concentrations (Ludolph et al., 2010). Recent evidence suggests that drugs
currently used to treat ADHD decrease NMDA receptor expression (Udvardi et
al., 2013; Urban, Li, & Gao, 2013).
Given the growing interest in NMDA receptors in impulsivity, the current
experiment sought to determine if NMDA receptor binding is altered in HiI and
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LoI impulsive rats. The results showed that NMDA receptor density within NAcc
and NAcSh did not differ significantly in HiI and LoI rats. Considering NMDA
receptors are upregulated following MK-801 administation (McDonald,
Silverstein, & Johnston, 1990), the hypothesis of the current experiment was that
HiI rats would have decreased NMDA receptor expression in NAcc relative to LoI
rats. The current results suggest that differential sensitivity to delayed
reinforcement does not result from baseline differences in NMDA receptor
expression in NAc.
Interpreting the current results is somewhat difficult for a couple of
reasons. First, NMDA receptors are composed of different subunits: NR1 and
NR2 (A-D; see Ozawa et al., 1998). Using the current protocol, [3H]MK-801
binding does not show selectivity for NMDA receptor NR2 subunits. Examining
NMDA subunit expression (e.g., using [3H]ifenprodil to target NR2B containing
receptors) in HiI and LoI rats may provide some insight for the individual
differences observed in delay discounting performance. Second, MK-801 blocks
synaptic and extrasynaptic NMDA receptors (Xia, Chen, Zhang, & Lipton, 2010).
Synaptic NMDA receptors are functional receptors that are activated by Glu
released during low-frequency synaptic events, whereas extrasynaptic receptors
are not activated during low-frequency synaptic events are found at various
locations on a neuron (see Hardingham & Bading, 2010 for a review). Future
work will need to determine if HiI and LoI rats differ in the number of synaptic or
extrasynaptic NMDA receptors.

	
  

53

	
  

Studying DAT binding in the NAc was of interest because DAT is believed
to mediate impulsive behavior, as administration of DAT inhibitors are efficacious
in treating impulse control disorders (see Biederman & Faraone, 2005) and
decrease impulsive choice in humans (de Wit et al., 2002; Pietras, Cherek, Lane,
Tcheremissine, & Steinberg, 2003; Shiels et al., 2009) and animals (Baarendse &
Vanderschuren, 2012; Broos et al., 2012; Floresco et al., 2008; Pitts & McKinney,
2005; van Gaalen et al., 2006). Also, DAT binding is lower in individuals with
ADHD (Krause, Dresel, Krause, Kung, & Tatsch, 2000). In the current
experiment, there were no differences in DAT density within NAcc and NAcSh
between HiI and LoI rats. These results were somewhat surprising because
previous studies have shown that lentiviral-mediated overexpression of DAT in
the NAcc increases impulsive choice (Adriani et al., 2009) and that LoI rats have
greater electrically evoked DA release within NAcc and NAcSh (Diergaarde et al.,
2008). Despite these discrepancies, the current findings are consistent with data
showing no correlation between impulsive choice and DAT function (as assessed
with kinetic analysis of [3H]DA uptake) within OFC or mPFC (Marusich, Darna,
Charnigo, Dwoskin, & Bardo, 2011). Directly comparing the current results with
previous studies is difficult because the methodologies used to assess the
relationship between DAT and impulsive decision differed across studies (e.g., in
vitro receptor autoradiography vs. electrically evoked DA release).
One major caveat of in vitro autoradiography needs to be discussed.
Autoradiography provides a measure of the number of receptors/transporters in a
brain region but does not identify functional differences. Although the number of
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NMDA receptors or DATs did not differ in the NAcc between HiI and LoI rats,
there is a possibility that functional differences exist. For example, Diergaarde et
al. (2008) found reduced DA release in mPFC and NAc of HiI rats relative to LoI
rats. Using alternative approaches that measure receptor/transporter function
are needed to determine the precise phenotypic differences in HiI and LoI
animals. Despite this caveat, the current results show that differences in delay
discounting are not necessarily the result of baseline differences in NAc NMDA
receptor or DAT expression.

	
  

55

	
  

High Impulsive

A

Proportion of
Choices
for Large Reward

1.0
0.8
0.6
0.4
0.2
0.0

0

5

10

20

50

Delay
Low Impulsive

B

Proportion of
Choices
for Large Reward

1.0
0.8
0.6
Sessions 1-4
Sessions 5-8
Sessions 9-12
Sessions 13-16
Sessions 17-20
Sessions 21-24
Sessions 25-28

0.4
0.2
0.0

0

5

10

20

50

Delay

Figure 3.1. Delay discounting performance in HiI rats (Panel A) and LoI rats
(Panel B) across session blocks (average of four sessions per block).
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Figure 3.3. Schematic showing the location of NAcc (outlined in solid line) and
NAcSh (outlined in dashed line).
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Figure 3.4. Representative autoradiograms of [3H]-MK-801 radioligand NMDA
receptor binding (Panel A) and [125I]-RTI-121 radioligand DAT binding (Panel B).
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Figure 3.5. Binding densities of [3H]-MK-801 to NMDA receptors (Panel A) and
[125I]-RTI-121 to DAT (Panel B) in HiI and LoI rats.
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Chapter 4: Experiment 3
Introduction
Although MK-801 decreased impulsive choice in Experiment 1,
interpreting the results can be difficult considered MK-801 blocks nicotinic
acetylcholine receptors (Amador & Dani, 1991; Briggs & McKenna, 1996) and
increases DA levels within the prefrontal cortex (Tsukada et al., 2005). To better
evaluate the role of Glu NMDA receptors in impulsive decision making, a drug
that shows higher selectivity for NMDA receptors can be administered. One such
drug is AP-5, which is competitive antagonist at NMDA receptors (Crunelli,
Forda, & Kelly, 1983).
Another issue is that using MK-801 as a pharmacotherapy for impulse
control disorders is not ideal because MK-801 disrupts learning in animals
(Harder, Aboobaker, Hodgetts, & Ridley, 1998; Li et al., 2011; Rapanelli, Frick,
Bernardez-Vidal, & Zanutto, 2013; van der Staay, Rutten, Erb, & Blokland, 2011)
and is often used to model symptoms of schizophrenia (see Lim, Taylor, &
Malone, 2012 for a review). One potential alternative approach is to use an
antagonist that targets a specific splice variant of the NMDA receptor, as eight
variants of the NR1 subunit (1a-4a; 1b-4b) and four variants of the NR2 subunit
(A-D) have been identified (Hollmann et al., 1993; Monyer et al., 1992; see
Ozawa et al., 1998 for a review). One such drug is ifenprodil, which selectively
antagonizes NR2B-containing NMDA receptors (Perin-Dureau, Rachline, Neyton,
& Paoletti, 2002). Ifenprodil is neuroprotective in in vivo models of ischemia
(Gotti et al., 1988), but lacks the psychomimetic-like effects observed with NMDA
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receptor antagonists like MK-801 (Narita, Aoki, & Suzuki, 2000). Furthermore,
ifenprodil attenuats the rewarding effects of opiates (Ma, Yu, Guo, & Cui, 2011;
Ma et al., 2006; Suzuki, Kato, Tsuda, Suzuki, & Misawa, 1999), suggesting that
NR2B subunits are important mediators of the drug addiction process.
Thus, the primary goal of Experiment 3 was to determine the effects of
intra-NAcc infusions of MK-801, AP-5, and ifenprodil on delay discounting
performance. Animals also received infusions of the AMPA receptor antagonist
CNQX. CNQX was included as a negative control, as the results from
Experiment 1 showed that CNQX does not alter impulsive decision making. The
primary hypothesis of this study was that intra-NAcc infusions of NMDA receptor
antagonists would decrease impulsive choice.
A secondary goal was to examine the effects of intra-NAcc infusions of
selective DA receptor ligands on impulsive choice. Typically, increasing DA
levels decreases impulsive choice (e.g., Broos et al., 2012a; Cardinal, Robbins,
& Everitt, 2000; de Wit et al., 2002; Pitts & McKinney, 2005; van Gaalen, van
Koten, Schoffelmeer, & Vanderschuren, 2006b; Winstanley et al., 2003). Thus,
the hypothesis was that stimulating D1-like receptors with SKF-38393 or blocking
D2-like autoreceptors with eticlopride would decrease impulsive choice.
Materials and Methods
Animals
A total of 24 male, individually-housed Sprague Dawley rats (Harlan
Industries; Indianapolis, IN) were used in the experiments. Rats weighed
	
  

62

	
  

approximately 250-275 g upon arrival to the laboratory. Rats were acclimated to
a colony room held at a constant temperature and were handled for 5 days upon
arrival. Light and dark phases were on a 12:12 h cycle, and all experiments
occurred during the light phase. Rats were food restricted (approximately 80% of
free feed body weight) 3 days before the beginning of behavioral training, and
rats remained on food restriction during the remainder of the study, unless
otherwise noted.
Drugs
(+)-MK-801 hydrogen maleate, D(-)-2-amino-5-phosphonopentanoic acid,
6-cyano-7-nitroquinoxaline-2,3-dione disodium salt hydrate, (±)-SKF-38393
hydrochloride, (±)-SCH-23390 hydrochloride, (-)-quinpirole hydrochloride, and S(-)-eticlopride hydrochloride were purchased from Sigma Aldrich (St. Louis, MO).
Ifenprodil hemitartrate was purchased from Tocris Bioscience (Ellisville, MO).
Each drug was prepared in sterile 0.9% NaCl (saline), and concentrations were
calculated based on salt weight.
Apparatus
The apparatus was identical to the one used in the Experiment 1.
Procedure
The procedures were identical to those described in Experiment 2.

	
  

63

	
  

Surgery
After 32 sessions of delay discounting, rats were treated with the
nonopioid analgesic carprofen one day prior to surgery. Rats were anesthetized
with a mixture of ketamine, xylazine, and acepromazine (75, 7.5, and 0.75 mg/kg,
i.p., respectively) and were secured into a stereotaxic frame. Cannulae were
implanted bilaterally into NAcc (+1.6 AP, ± 1.5 ML, -5.5 DV) at the 10° angle off
the midline; Paxinos & Watson, 1998). Following surgery, rats were treated with
carprofen for two days.
Microinfusions
Rats recovered for 3-5 days and were food restricted before receiving 12
additional training sessions in the delay discounting task. This additional training
was important to ensure that surgery did not alter discounting behavior. For
intracranial infusions, rats were gently restrained by the experimenter, and a
stainless-steel injection cannula (33 gauge; Small Parts, Inc, Miramar, FL) was
inserted 2 mm below the tip of the guide cannulae. The cannulae were
connected to 10 µl syringes (Hamilton, Reno, NV) via PE10 tubing (Small Parts,
Inc, Miramar, FL). The Hamilton syringes were mounted on an infusion pump
(KDS Scientific, Holliston, MA). Half of the rats (n = 12) received direct infusions
of ionotropic glutamate receptor ligands MK-801 (noncompetitive NMDA channel
blocker; 0.0, 0.3, and 1.0 µg/0.5 µl; Bakshi & Geyer, 1998; Zhang, Bast, &
Feldon, 2000), AP-5 (competitive NMDA antagonist; 0.0, 0.3, and 1.0 µg/0.5 µl;
Baldwin, Holahan, Sadeghian, & Kelley, 2000; Dar, 2002; Sombers, Beyene,
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Carelli, & Wrightman, 2009), ifenprodil (NR2B subunit antagonist; 0.0, 0.3, and
1.0 µg/0.5 µl; Parkes & Balleine, 2013; Laurent & Westbook, 2008), and CNQX
(AMPA antagonist; 0.0, 0.2 and 0.5 µg/0.5 µl; Hitchcott & Phillips, 1997;
Mesches, Bianchin, & McGaugh, 1996). The other half of the rats (n = 12)
received direct infusions of the dopamine receptor ligands SKF 38393 (D1-like
agonist; 0.0, 0.03 and 0.1 µg/0.5 µl; Loos et al., 2010; Yates et al., under review),
SCH 23390 (D1-like antagonist; 0.0, 0.3, and 1.0 µg/0.5 µl; Loos et al., 2010;
Yates et al., under review; Zeeb et al., 2010), quinpirole (D2-like agonist; 0.0, 0.3,
and 1.0 µg/0.5 µl; Yates et al., under review), eticlopride (D2-like antagonist; 0.0,
0.3, and 1.0 µg/0.5 µl; Yates et al., under review; Zeeb et al., 2010). Each drug
was infused over 2 min at a rate of 0.25 µl/min. Injectors were left in place for 1
min following the infusion. Rats were placed into the operant chamber
immediately following the infusion. Treatments were randomly administered, and
rats were given 2 days of washout following each infusion; rats were tested in
delay discounting during these washout days.
Following the last day of infusions, rats were anesthetized with ketamine,
and brains were removed and flash-frozen in chromasolv (Sigma) on dry ice and
stored at -80°C until sectioning was completed. Brain sections (40 µm) were
sliced to determine the location of guide cannulae. Probe placements were
evaluated according to the atlas of Paxinos and Watson (1998). Only data from
rats with correct probe placements in NAcc were used in statistical analyses.
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Statistical Analyses
To determine if implantation of guide cannulae into NAcc altered
sensitivity to delayed reinforcement or sensitivity to reinforcer magnitude,
discounting performance before surgery (average of final four sessions) was
compared to discounting performance after surgery (average of final four
sessions before first microinfusion). Parameter estimates of k (log transformed)
and A were analyzed with a mixed-factor ANOVA, with surgery (Pre vs. Post) as
a within-subjects factor and experiment (Glu vs. DA) as a between-subjects
factor. For each individual experiment, omissions and parameter estimates from
the hyperbolic discounting function were analyzed as described in Experiment 1.
Results
Figure 4.1 shows the proportion of choices for the large, delayed
reinforcer as a function of delay averaged across the final four sessions before
surgery and averaged across the final four sessions after surgery, prior to the
first microinfusion of either Glu-selective ligands or DA-selective ligands.
Analysis of k and A parameter estimates revealed that surgery did not alter
sensitivity to delayed reinforcement or sensitivity to reinforcer magnitude (Figure
4.2). Furthermore, baseline levels of discounting were similar for animals
selected to subsequently receive Glu-selective ligands and DA-selective ligands
(Figure 4.2).
Figure 4.3 shows a representative image of bilateral guide cannulae
implantation into NAcc. Four rats in Experiment 1A (Figure 4.4) and six rats in
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Experiment 1B (Figure 4.5) had probe placements outside of NAcc, and were
thus excluded from further analyses
Figures 4.6 and 4.7 show the proportion of choices for the delayed
reinforcer following all concentrations of MK-801, AP-5, ifenprodil, and CNQX.
The proportion of choices for the large delayed reinforcer decreased as function
of the delay to receiving reinforcement.
Figures 4.8 and 4.9 show omissions following all concentrations of MK801, AP-5, ifenprodil, and CNQX. AP-5 increased overall omissions (χ2(2) =
8.00, p < .05), although Wilcoxon post hoc tests did not reveal significant
differences between vehicle and either dose (each p > .025; Bonferroni
correction; Figure 4.8B). MK-801 (Figure 4.8A), ifenprodil (Figure 4.9A), and
CNQX (Figure 4.9B) did not alter omissions.
Figures 4.10 and 4.11 show k parameter estimates following all
concentrations of MK-801, AP-5, ifenprodil, and CNQX. None of the Gluselective ligands produced a statistically significant change in k parameter
estimates.
Figures 4.12 and 4.13 show A parameter estimates following all
concentrations of MK-801, AP-5, ifenprodil, and CNQX. None of the Gluselective ligands significantly altered sensitivity to reinforcer magnitude.
Figures 4.14 and 4.15 show the proportion of choices for the delayed
reinforcer following all concentrations of SKF 38393, SCH 23390, quinpirole, and
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eticlopride. The proportion of choices for the large delayed reinforcer decreased
as function of the delay to receiving reinforcement.
Figures 4.16 and 4.17 show omissions following all concentrations of SKF
38393, SCH 23390, quinpirole, and eticlopride. Intra-NAcc infusions of DAselective ligands did not alter omissions.
Figures 4.18 and 4.19 show k parameter estimates following all
concentrations of SKF 38393, SCH 23390, quinpirole, and eticlopride. None of
the DA-selective ligands produced a statistically significant change in k
parameter estimates.
Figure 4.20 and 4.21 show A parameter estimates following all
concentrations of SKF 38393, SCH 23390, quinpirole, and eticlopride. None of
the DA-selective ligands altered sensitivity to reinforcer magnitude.
Discussion
In the current experiment, intra-NAcc infusions of NMDA-selective ligands
and DA-selective ligands did not significantly alter delay discounting. Although
none of the ligands infused into NAcc caused a statistically significant difference
in the rate of discounting using traditional statistical methods, this does not mean
that Glu and DA receptors within this region do not necessarily mediate impulsive
choice. Large effect sizes were reported for MK-801, ifenprodil, SKF 38393, and
eticlopride (Cohen’s f’s > .60), indicating that these drugs decreased impulsive
choice. One potential reason a statistical difference was not detected for these
drugs is the small sample sizes used in each experiment (Glu experiment: n = 8;
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DA experiment: n = 6). Similarly, baseline levels of impulsive choice may
influence the effects of intra-NAcc infusions. For example, administration of
methylphenidate increases delay discounting in LoI rats, but decreases
discounting in HiI rats (Perry, Stairs, & Bardo, 2008b). Due to the relatively small
sample sizes, examining the effects of Glu-selective and DA-selective drugs on
discounting in HiI and LoI rats was not feasible.
It has been argued that research needs to switch from null-hypothesis
testing (i.e., reporting p values) to using effect sizes estimates (i.e., Cohen’s d,
Cohen’s f, eta squared; Cumming, 2014; Kirk, 2003). Other critics of nullhypothesis testing argue that hypothesis testing impedes scientific progress
(Kirk, 2003), and some have even suggested that some research findings are
false because hypothesis testing creates bias in data interpretation (Ioannidis,
2005). Based on effect size estimates, the current data provide some evidence
that blockade of NR2B containing NMDA receptors and DA receptors within
NAcc mediate impulsive decision making.
In Experiment 1, systemic administration of MK-801 significantly
decreased impulsive choice. However, intra-NAcc MK-801 infusions did not
significantly decrease sensitivity to delayed reinforcement. One possibility for
this discrepancy is that direct infusion of MK-801 (1.0 µg) lesioned the NAcc (see
Olney, Labruyere, & Price, 1989 for a discussion). However, this interpretation
does not seem likely, as lesions to NAcc increase impulsive choice (e.g.,
Cardinal et al., 2001). Also, considering that the effect size estimates obtained
for MK-801 in Experiment 1 (Cohen’s f = .67) and the current experiment
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(Cohen’s f = .61), the current results provide some support that intra-NAcc
infusions of MK-801 decrease impulsive choice.
The current experiment provided some evidence that direct administration
of ifenprodil decreased impulsive choice (Cohen’s f = .62). Thus, the NR2B
subunit may be an important mediator of impulsive decision making. This
interpretation is further supported by the finding that intercereboventricular and
intra-NAcc administration of the competitive NMDA receptor antagonist AP-5
does not affect delay discounting (Cottone et al., 2013; current experiment).
Considering that selective blockade of NR2B subunits does not produce
amnesiac or dissociative effects like noncompetitive channel blockers (e.g., MK801; Narita et al., 2000), ifenprodil may be a promising pharmacotherapy for
treating impulse control disorders. Furthermore, ifenprodil has been shown to be
effective in attenuating the rewarding effects of opiates (Ma et al., 2011; Ma et
al., 2006; Suzuki et al., 1999). Future studies will need to test the efficacy of
ifenprodil in reducing the reinforcing effects of psychostimulants, although one
report showed that ifenprodil blocks the discriminative stimulus effects of cocaine
in monkeys (Fujiwara et al., 2007). Furthermore, future work is needed to test the
effectiveness of therapeutically relevant doses of ifenprodil in reducing
impulsivity.
DA systems are thought to play a critical role in impulsive choice,
especially in delay discounting (see Winstanley, 2011 for a review). Considering
that medications used to treat impulse control disorders release DA levels (see
Biederman & Faraone, 2005) and decrease impulsive decision making (Broos et
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al., 2012a; Cardinal et al., 2000; de Wit et al., 2002; Pitts & McKinney, 2005; van
Gaalen et al., 2006b; Winstanley et al., 2003), it was hypothesized that
increasing SKF 38393 (D1-like agonist) and eticlopride (D2-like antagonist)
would decrease impulsive choice. Increasing DA levels by stimulating D1-like
receptors and inhibiting D2-like autoreceptors did not significantly alter delay
discounting. Similar to the results with MK-801 and ifenprodil, the effect sizes
reported for SKF 38393 (Cohen’s f = .64) and eticlopride (Cohen’s f = .61) were
large, which provides some support for the hypotheses. Regardless, these data
do not corroborate previous research examining the role of DA receptor ligands
in impulsive decision making. A previous study found increased discounting
following intra-mPFC infusions of SKF 38393 (Loos et al., 2010). Loos et al.
(2010) also observed increases in impulsive choice after blocking D1-like
receptors with SCH 23390, an effect not observed in the current experiment.
Given that the discounting procedure used by Loos et al. (2010) was similar to
the current procedure, it is not entirely clear why discounting was differentially
altered following SKF 38393 administration. However, intra-mPFC administration
appears to have produced a slight decrease in choice for the large magnitude
reinforcer when its delivery was immediate (Loos et al., 2010), an effect observed
following systemic administration (Koffarnus et al., 2011). Thus, D1 receptors
within mPFC and NAcc may differentially mediate sensitivity to reinforcer amount
and delayed reinforcement.
DA D2-like receptors are autoreceptors, which decrease DA synthesis and
packaging (Onali, Oliansa, & Bunse, 1988; Pothos, Davila, & Sulzer, 1998).
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Therefore, blocking these receptors should decrease the rate of discounting.
However, previous studies have observed increases in impulsive choice following
intra-mPFC or intra-OFC administration of the D2-like receptor antagonists
raclopride and eticlopride (Pardey et al., 2013; Zeeb et al., 2010). One
discrepancy between the current experiment and previous studies is the use of a
discriminative stimulus to signal the delay to delivery of the large magnitude
reinforcer. In the current experiment, no cue was used to signal the delay,
whereas Pardey et al. (2013) and Zeeb et al. (2010) used a cue light. Zeeb et al.
(2010) found that eticlopride increased impulsive choice when a cue was used,
whereas impulsive choice was unaltered if a cue was not used. Thus, future
studies are needed to understand how intra-NAcc administration of DA D2-like
antagonists affect impulsive decision making when cues are used to signal the
delay to reinforcement.
One limitation to this study was the use of two concentrations for each
drug tested. The number of drug concentrations was limited because the
number of microinfusions needs to be limited in order to minimize damage to the
brain region. Future work will be needed to assess a wider range of drug
concentrations of NMDA and DA receptor ligands within NAcc and NAcSh to
further elucidate the role of NAc Glu and DA systems in controlling impulsive
choice. Furthermore, examining the role of other neurotransmitter systems within
NAc is merited. For example, NAc contains 5-HT and GABA receptors (Biegon,
Rainbow, & McEwen, 1982; Bowery, Hudson, & Price, 1987), and these
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neurotransmitters influence impulsive decision making (Bizot et al., 1999; Liu et
al., 2004; Zeeb et al., 2010).
Another important consideration is that several brain regions have been
implicated in impulsive decision making, such as OFC (Mobini et al., 2002;
Winstanley et al., 2004b; but see Churchwell et al., 2009), mPFC (Churchwell et
al., 2009; but see Cardinal et al., 2001), amygdala (Churchwell et al., 2009;
Winstanley et al., 2004b), dorsal striatum (Dunnett et al., 2012), and
hippocampus (Abela & Chudasama, 2013; Cheung & Cardinal, 2005; Mariano et
al., 2009). Also, DA receptors within OFC and mPFC are known to contribute to
delay discounting performance (Loos et al., 2010; Yates et al., under review;
Zeeb et al., 2010). Future studies are needed to assess the role of NMDA
receptors in other brain regions (e.g., frontal cortices and hippocampus) in
mediating impulsive behavior.
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Figure 4.1 Mean (± SEM) proportion of choices for the large magnitude
reinforcer as a function of the delay to receiving reinforcement before and after
surgery in rats subsequently given Glu-selective ligands and DA-selective
ligands.
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Figure 4.3. Representative image of bilateral guide cannulae implantation into
NAcc.
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Figure 4.4. Schematic of coronal sections showing probe placements for rats
infused with Glu-selective ligands. Black circles indicate probe placements within
NAcc, whereas crosses indicate probe place placements outside of NAcc. Note
that rats with probe placements outside of NAcc were excluded from data
analysis. Numbers beside each plate correspond to mm anterior to bregma.
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Figure 4.5. Schematic of coronal sections showing probe placements for rats
infused with DA-selective ligands. Black circles indicate probe placements within
NAcc, whereas crosses indicate probe place placements outside of NAcc. Note
that rats with probe placements outside of NAcc were excluded from data
analysis. Numbers beside each plate correspond to mm anterior to bregma.
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Figure 4.6. Mean (± SEM) proportion of choices for the large magnitude
reinforcer as a function of the delay to receiving reinforcement following intraNAcc infusions of MK-801 (Panel A) and AP-5 (Panel B).
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Figure 4.7. Mean (± SEM) proportion of choices for the large magnitude
reinforcer as a function of the delay to receiving reinforcement following intraNAcc infusions of ifenprodil (Panel A) and CNQX (Panel B).
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Figure 4.9. Mean (± SEM) omissions during free-choice trials following intraNAcc infusions of ifenprodil (Panel A) and CNQX (Panel B).
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Figure 4.10. Mean (± SEM) k parameter estimates (log transformed) following
intra-NAcc infusions of MK-801 (Panel A) and AP-5 (Panel B).
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Figure 4.11. Mean (± SEM) k parameter estimates (log transformed) following
intra-NAcc infusions of ifenprodil (Panel A) and CNQX (Panel B).
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Figure 4.12. Mean (± SEM) A parameter estimates following intra-NAcc infusions
of MK-801 (Panel A) and AP-5 (Panel B).
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Figure 4.13. Mean (± SEM) A parameter estimates following intra-NAcc infusions
of ifenprodil (Panel A) and CNQX (Panel B).
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Figure 4.14. Mean (± SEM) proportion of choices for the large magnitude
reinforcer as a function of the delay to receiving reinforcement following intraNAcc infusions of SKF 38393 (Panel A) and SCH 23390 (Panel B).
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Figure 4.15. Mean (± SEM) proportion of choices for the large magnitude
reinforcer as a function of the delay to receiving reinforcement following intraNAcc infusions of quinpirole (Panel A) and eticlopride (Panel B).
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Figure 4.16. Mean (± SEM) omissions during free-choice trials following intraNAcc infusions of SKF 38393 (Panel A) and SCH 23390 (Panel B).
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Figure 4.17. Mean (± SEM) omissions during free-choice trials following intraNAcc infusions of quinpirole (Panel A) and eticlopride (Panel B).
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Figure 4.18. Mean (± SEM) k parameter estimates (log transformed) following
intra-NAcc infusions of SKF 38393 (Panel A) and SCH 23390 (Panel B).
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Figure 4.19. Mean (± SEM) k parameter estimates (log transformed) following
intra-NAcc infusions of quinpirole (Panel A), and eticlopride (Panel B).
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Figure 4.20. Mean (± SEM) A parameter estimates following intra-NAcc infusions
of SKF 38393 (Panel A) and SCH 23390 (Panel B).
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Figure 4.21. Mean (± SEM) A parameter estimates following intra-NAcc infusions
of quinpirole (Panel A) and eticlopride (Panel B).
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Chapter 5: General Discussion
The primary goal of the current set of experiments was to elucidate the
role of the glutamatergic and dopaminergic systems in impulsive choice. The
NAcc has been consistently linked to impulsive decision making (Bezzina et al.,
2007; Cardinal et al., 2001; da Costa Araújo et al., 2009; Pothuzien et al., 2005;
Valencia-Torres et al., 2012); however, studies examining the role of NAcc in
impulsive choice have relied on excitotoxic lesions. Lesion studies do not
indicate which specific neurotransmitter systems mediate this behavior.
Therefore, the current experiments sought to determine if NAcc Glu and DA
systems are a) altered in HiI and LoI animals, and b) to determine if NAcc Glu
and DA receptors differentially alter impulsive choice. The results from these
studies demonstrated that: 1) systemic administration of MK-801, but not CNQX,
decreases impulsive choice (Experiment 1); 2) differences in discounting do not
result from baseline differences in NAc NMDA receptor or DAT expression
(Experiment 2); and 3) intra-NAcc infusions of Glu-selective and DA-selective
ligands do not significantly alter impulsive choice (Experiment 3).
In the current experiments, the term “impulsive choice” has been used to
describe performance in delay discounting. Although delay discounting is often
described as a measure of impulsive choice (e.g., Ainslie, 1975; see Winstanley
et al., 2010 for a review), some argue against this assertion. For example,
Blanchard, Pearson, and Hayden (2013) show that monkeys often fail to
associate postreward delays with their choices and systematically underestimate
the delay to reinforcement. Blanchard et al. (2013) propose that discounting
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does not necessarily reflect impulsivity, but may reflect other unrelated mental
processes. Furthermore, Killeen (2011) postulates that animals do not discount
future rewards; instead, the data observed in discounting experiments merely
reflects decay in memory traces.
Despite these criticisms, studying delay discounting is important because
performance in this task is often linked to maladaptive behaviors, such as
pathological gambling (Petry, 2001b) and substance use disorders (Bickel et al.,
1999; Coffey et al., 2003; Madden et al., 1997; Mitchell, 1999; Vuchinich &
Simpson, 1998). As discussed in Chapter 1, animals showing increased
sensitivity to delayed reinforcement are more likely to acquire psychostimulant
self-administration at a faster rate (Perry et al., 2005, 2008a), to respond more
for drug reinforcers (Diergaarde et al., 2008; Marusich & Bardo, 2009), and to be
more susceptible to relapse-like behaviors (Diergaarde et al., 2008).
It should be noted that delay discounting is not the only measure of
impulsivity that is linked to drug abuse. As with impulsive choice, the construct of
impulsive action (i.e., behavioral disinhibition or motor impulsivity) has received
considerable attention in the drug abuse field. Cocaine (Fillmore & Rush, 2002;
Li, Milivojevic, Kemp, Hong, & Sinha, 2006) and methamphetamine (Monterosso,
Aron, Cordova, Xu, & London, 2005) users display inhibitory deficits in a SSRT
task relative to nonusers. Furthermore, cocaine users (Hester & Garavan, 2004;
Kaufman, Ross, Stein, & Garavan, 2003; Verdejo-Garcia, Perales, & PerezGarcia, 2007) and alcoholics (Noel et al., 2007) show increased inhibitory deficits
on a go/no-go task compared to controls. Impulsive action is predictive of drug
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abuse vulnerability, as rats that exhibit increased impulsivity in the 5CSRT task
show escalation of cocaine self-administration (Dalley et al., 2007), compulsive
cocaine self-administration (Belin, Mar, Dalley, Robbins, & Everitt, 2008), and
reinstatement of cocaine self-administration (Economidou, Pelloux, Robbins,
Dalley, & Everitt, 2009).
Like impulsive choice, motor impulsivity is altered by various drugs, and
this effect is observed in humans and animals. Alcohol generally impairs
inhibitory control in humans (de Wit, Crean, & Richards, 2000; Easdon, Izenberg,
Armilo, Yu, & Alain, 2005; Fillmore & Vogel-Spott, 1999; Marczinski, Abroms,
Van Selst, & Fillmore, 2005; Marczinski & Fillmore, 2003, 2005a, b; Mulvihill,
Skilling, & Vogel-Sprott, 1997; but see Ortner, MacDonald, & Olmstead, 2003)
and animals (Feola et al., 2000). Also, cocaine administration increases
impulsive action in humans (Fillmore, Rush, & Hays, 2002) and animals (Paine &
Olmstead, 2004; van Gaalen, Brueggeman, Bronius, Schoffelmeer, &
Vanderschuren, 2006a; Winstanley et al., 2009).
Although impulsive choice and impulsive action are both linked to
substance abuse, it should be emphasized that there is evidence that these
facets of impulsivity are dissociable. In humans and animals, impulsive choice
and impulsive action are not correlated (Broos et al., 2012; Marusich et al.,
2011). Also, lesions to the subthalamic nucleus decreases impulsive choice
(Winstanley, Baunez, Theobald, & Robbins, 2005) but increase impulsivity as
assessed in the 5CSRT task (Baunez et al., 2001) and impair prepotent
response inhibition (Weiner, Magaro, & Matell, 2008). Also, damage to OFC
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alters delay discounting performance, albeit discrepancies have been reported in
the literature (Mar et al., 2011; Mobini et al., 2002; Kheramin et al., 2002, 2004;
Rudebeck et al., 2006; Winstanley et al., 2004b), whereas damage to OFC does
not affect performance in the 5CSRT task (Chudasama et al., 2003).
Furthermore, Experiment 2 showed that HiI and LoI rats had similar DAT densitiy
within NAc, whereas a recent study found differential NAcSh DAT density in LoI
rats relative to HiI rats performing a 5CSRT task (Jupp et al., 2013).
Understanding the precise underlying neuromechanisms involved in distinct
facets of impulsivity is important for providing effective pharmacotherapies for
those who display different types of impulsive behavior. Results from Experiment
3 suggest that ifenprodil may be an effective treatment for reducing impulsive
decision making. It is unknown if ifenprodil will reduce motor impulsivity,
although there is evidence that blockade of NR2B subunit with Ro 63-1908
increases impulsive action (Burton & Fletcher, 2012; Higgims, Ballard, Huwyler,
Kemp, & Gill, 2003). Thus, targeting NR2B subunits may not be an effective
treatment for those who display increased motor impulsivity.
Although the current experiments focused on delay discounting, it is worth
mentioning that other discounting procedures exist. Specifically, the probability
discounting procedure has received some attention. This procedure is similar to
delay discounting, but the odds against obtaining the large magnitude reinforcer
increase (i.e., the probability of obtaining the reinforcer decreases). There is
some dispute as to whether delay and probability discounting measure similar
constructs of impulsivity. It has been proposed that delay and probability
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discounting reflect a similar underlying process (Myerson & Green, 1995; Rachlin
et al., 1991). In support of this proposal, the same mathematical functions (e.g.,
hyperbolic) can be used to model delay and probability discounting (Rachlin et
al., 1991). Also, administration of amphetamine produces similar shifts in delay
(van Gaalen et al., 2006b; Winstanley et al., 2003) and probability discounting
(Floresco & Whelan, 2009; St Onge & Floresco, 2009). Furthermore, lesions to
NAc increase the rate of discounting for delayed (Cardinal et al., 2001) and
probabilistic reinforcement (Cardinal & Howes, 2005).
An important consideration is that similar shifts in delay and probability
discounting following pharmacological manipulations does not necessarily mean
that these tasks reflect the same process. Evidence suggests that delay and
probability discounting involve distinct processes, with delay and probability
discounting reflecting impulsive choice and risky decision making, respectively
(Ainslie, 1975; Kahneman & Tversky, 1979). Although increased delay
discounting is postulated to reflect impulsive choice (Ainslie, 1975), decreased
probability discounting is proposed to reflect risky decision making (Kahneman &
Tversky, 1979). Thus, drugs that decrease the rate of discounting of delayed
and probabilistic reinforcement differentially alter impulsive behavior, with
decreased delay discounting reflecting higher self control and decreased
probability discounting reflecting increased risky decision making.
In line with this hypothesis, there is some support that delay and
probability discounting are dissociable, as manipulating reinforcer magnitude
differentially alters discounting of delayed and uncertain reinforcement (Green,
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Myerson, & Ostaszewski, 1999), and forebrain depletion of 5-HT increases
sensitivity to delayed reinforcement without altering sensitivity to probabilistic
reinforcement (Mobini et al., 2000). In addition to the data collected in
Experiment 1, a separate group of rats were administered MK-801 and CNQX
before performing a probability discounting task. As in delay discounting, MK801 (0.03 mg/kg) increased responding for the large, uncertain reinforcer,
whereas CNQX (5.6 mg/kg) decreased responding. Overall, these results
suggest that iGluRs differentially mediate impulsivity, with MK-801 decreasing
impulsive choice but increasing risky decision making and CNQX increasing
probability discounting without altering delay discounting. Future work will need
to assess the effects of ifenprodil on risky decision making to determine if
selective NR2B antagonists attenuate risky decision making. Moreover, perhaps
probability discounting would be an alternative approach for examining the
specific role of DA and Glu systems in impulsive decision making using the
current autoradiographic and microinjection techniques.
One caveat to the current studies is that the delay to the large magnitude
reinforcer increased across each block of trials. The rate of discounting can be
influenced by the order in which delays/odds against are presented (e.g,
ascending, descending, or mixed order; Fox et al., 2008; Robles and Vargas
2007, 2008; but see Slezak and Anderson 2009). Furthermore, drug effects can
be dependent on the order in which delays are presented (Tanno, Maguire,
Henson, & France, 2014). Specifically, Tanno et al. (2014) show that
amphetamine and methylphenidate increase choice for the large, delayed
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reinforcer when delays are presented in an ascending order, whereas a decrease
in choice for the large reinforcer is observed when delays are presented in a
descending order. One could argue that the increase in responding for the large
magnitude reinforcer observed in Experiments 1 and 3 following NMDA and DA
D2-like receptor blockade or DA D1-like receptor activation could reflect an
increase in the persistence of choice behavior rather than a change in sensitivity
to delay. Future work will need to randomize the order in which delays are
presented in order to avoid this potential confound.
Another caveat to the current study relates to the upward shift in the
discounting function following MK-801, ifenprodil, SKF 38393, and eticlopride
administration. Interpretation of these findings is difficult because we cannot rule
out the possibility that the upward shift in discounting was attributed to increased
sensitivity to reinforcer magnitude. Indeed, a change in the A parameter
(sensitivity to reinforcer magnitude) was observed following MK-801
administration in the delay discounting task in Experiment 1. Because the
proportion of choices for the large magnitude reinforcer is close to a ceiling (near
1.0) when the delay to its delivery is set at 0 sec, an increase in responding for
that reinforcer is difficult to observe following pharmacological manipulations.
For example, certain drugs decrease responding for a large, delayed/uncertain
reinforcer, even when the delay to its delivery is set at 0 sec (Cardinal et al.,
2000; Koffarnus et al., 2011; Mendez et al., 2012; van Gaalen et al., 2006b;
Winstanley et al., 2005).
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Although promising, results from the current experiments are not fully
conclusive about the specific role DA and Glu in NAcc, if any, in delay
discounting and follow-up experiments are needed. Considering the complex
interactions between Glu and monoamine neurotransmitters (DA and 5-HT)
within the mesocorticolimbic pathway (see Tzschentke, 2001 for a review), future
studies should examine how these interactions control impulsive choice. For
example, there is evidence for DA:5-HT interactions to mediate impulsive
choice, as DA depletions within NAc block impulsivity induced by a 5-HT1A
receptor agonist (Winstanley et al., 2005). Also, there is some evidence for
Glu:5-HT interactions, as administration of a mGluR2/3 receptor agonist
attenuates 5-HT2A-induced impulsive choice (Wischof et al., 2011). These
studies can help further our understanding of the role of the glutamatergic system
in impulsive choice.

Copyright © Justin Ryan Yates 2014
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